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A b s t r a c t
The following report attempted to show the true sub cellular location of human xanthine 
oxidoreducatse (XOR) and, together with cellular activity studies, assign a physiological function 
for the enzyme.
Localisation of XOR was facilitated by a high specificity anti-human XOR monoclonal antibody. 
Localisation was studied in human endothelial and mammary and gut epithelial permenant cell 
lines. Both confocal microscopy and electron microscopy was used. In all the cell lines XOR 
appeared in discrete punctate pockets and this, along with an association with the golgi apparatus, 
gave strong indication that the enzyme was being trafficked through the cell in vesicles. The 
destination of the enzyme varied in all three cell types although in all cases it seemed to be destined 
for secretion and then attachment to the outside of the plasma membrane.
The localisation and activity in endothelial cells supported a role for XOR in NO mediated 
vasodilation. This occurred under hypoxic conditions, indicating that the enzyme could be 
complimenting the oxygen dependent nitric oxide synthase (NOS). The localisation and activity of 
XOR in mammary epithelial cells, along with other work studying the enzyme in human milk, 
strongly suggested that XOR produced superoxide, NO and peroxynitrite served an anti-microbial 
role in the neonatal gut. A similar role was suggested for XOR in gut epithelial cells, with the 
localisation giving a strong indication that the enzyme may serve to produce an anti-microbial 
response upon breach of the gap junction between enterocytes.
Overall the most striking evidence was that the enzyme appeared to be trafficked through the 
secretion pathway of all the cells studied.
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ATP — adenosine triphosphate
BBB -  blood brain barrier
BRLE -  buffalo rat epithelial cell line
BSA -  bovine serum albumin
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ECACC -  European collection of cell cultures
EDTA -  ethylenediaminetetraacetic acid disodium salt dihydrate
ELISA -  enzyme linked immunosorbent assay
ER -  endoplasmic reticulum
FAD -  flavine adenine dinucleotide
FBS -  foetal bovine serum
FeS -  iron sulphur
FITC -  fluorescein isothiocyanate
GTN -  glyceryl trinitrate
HBSS -  hanks buffered saline solution
HUVEC -  human umbilical vein endothelial cell
IgG -  immunoglobulin G
IgM -  immunoglobulin M
IR -  ischemia reperfusion
KDa -  kiloDaltons
Mo -  molybdenum
NAD+ -  nicotinamide adenine dinucleotide 
NADH -  reduced nicotinamide adenine dinucleotide
NADPH -nicotinamide adenine phosphate dinucleotide
NO -  nitric oxide
NOS -  nitric oxide synthase
PBS -  phosphate buffered saline
rER -  rough endoplasmic reticulum
ROS -  reactive oxygen species
SDS -  sodium dodecyl sulphate
SDS PAGE -  sodium dodecyl sulphate polyacrylamide gel electrophoresis
TBS -  tris buffered saline
TRITC -  tetramethylrhodamine isothiocyanate
TUNEL -  transferase dUTP nick end labeling
UV -  ultra violet
XDH -  xanthine dehydrogenase
XO -  xanthine oxidase
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1 I n t r o d u c t io n
1.1 A brief introduction to xanthine oxidoreductase
Xanthine oxidoreductase (XOR) is a widely distributed molybdenum-containing flavoenzyme that 
plays a key role in purine catabolism, catalysing the hydroxylation of hypoxanthine and xanthine to 
xanthine and uric acid, respectively (Bray, 1975) with concomitant reduction of NAD+ or molecular 
oxygen.
XOR has been found in all species studied, from bacteria through to man. The level of amino acid 
identity among XOR species homologs is very high, indicating a remarkable level of conservation 
along phylogeny (Terao et al, 1997), see Fig 1.1. XOR is readily available from milk, where it 
forms a major component of the milk fat globule membrane (Bray, 1975). Because of this 
availability, the enzyme has been known for over 100 years and has been studied in purified form 
for the last 60 years (Massey and Harris, 1997).
XOR is a homodimer of 150kDa subunits and exists in two interconvertible forms, xanthine 
dehydrogenase (XDH) and xanthine oxidase (XO). Each monomeric subunit contains two Fe-S 
redox centers, an NAD+ and a molybdenum-cofactor-binding site (see Fig 1.2). The dehydrogenase 
form preferentially reduces NAD+, in contrast to the oxidase form, which does not reduce NAD+, 










Fig 1.1: Phylogenic tree showing the % identity to human liver XOR between species o f XOR. (Courtesy o f Arwen 
Pearson)
Interest in XOR has increased over the past few decades as our knowledge about its molecular 
activity has increased. Its ability to produce reactive oxygen (Granger et al 1981) and nitrogen 
(Millar et al, 1998) species has inspired a great deal of research and debate into the enzyme’s true 
physiological purpose and function.
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Fig 1.2 : A ribbon diagram depicting bovine XO. FAD and molybdopterin are shown as capped 
cylinders and the iron sulphur centres as atoms. The Mo domain is blue, the FAD domain green and 
the FeS domain red. (Courtesey o f Arwen Pearson)
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1.2 Enzvmology
While there are still no definitive answers as to the pathophysiological function of XOR, our 
knowledge of the structure and properties of the enzyme has greatly increased in recent years. XOR 
has been characterized from rat (Ikegami and Nishino, 1986), chicken (Nishino and Nishino, 1989) 
and turkey (Cleere and Coughlan, 1975) livers and from mouse mammaiy gland (McManaman et 
al, 1999) as well as from human (Godber, 1998) and bovine (Massey and Harris, 1997) milk. These 
preparations have demonstrated that the basic properties of the enzyme are generally consistent, no 
matter what the source.
1.2.1 Substrates
XOR catalyses the oxidation of a wide range of substrates, most notably hypoxanthine and 
xanthine, generating xanthine and uric acid, respectively, in the process of purine catabolism (see 
Fig 1.3) (Bray, 1975). It is also capable of oxidising purines, pteridines, aldehydes and various 
xenobiotics as well as reducing NAD+, oxygen and methylene blue (Krenitsky et al, 1972). The 
reduction of inorganic nitrites to NO is believed to occur at the molybdenum site with xanthine or 








Xanthine oxidase Xanthine oxidase
Xanthine Uric AcidHypoxanthine
Fig 1.3 : Catabolism o f purine nucleotides to uric acid
Reducing substrates donate electrons at the molybdenum site, except NADH, which is unique in its 
ability to donate electrons to the FAD site (see Fig 1.4). Electrons are shuttled between the 
molybdenum, iron-sulphur and FAD sites with the iron-sulphurs maintaining the other centres in 
the optimum redox state (in general, molybdenum for reducing substrates and FAD for oxidising 
substrates) by acting as electron resevoirs (Olson et al, 1974).
5
Fig 1.4 : Molecular activity o f XOR, purple lines show the flow o f substrates to products, white lines 
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1.2.2 Dehydrogenase and oxidase forms
As previously stated, XOR is a homodimer of 150kDa subunits and exists in two interconvertible 
forms, xanthine dehydrogenase (XDH) and xanthine oxidase (XO). XDH is the predominant form 
in vivo and the only form observed in avian sources (Bray, 1975). The two forms are interconverted 
reversibly by sulphide reagents or, irreversibly (XDH to XO) by proteolysis (Della-Corte et al 
1972).
XDH preferentially reduces NAD+, whereas XO cannot reduce NAD+, preferring molecular 
oxygen. The three dimensional structure of bovine milk XOR has been determined by Enroth et al 
(2000), who showed that XDH to XO conversion involved major changes in the FAD site.
1.2.3 Reactive oxygen species metabolism
Reduction of oxygen leads to superoxide anion and hydrogen peroxide, and it is the potential to 
generate these reactive oxygen species (ROS) that has led to particular interest in the enzyme as a 
destructive agent in many instances of ischaemia-reperfiision injury (Sussman and Bulkley, 1990). 
XOR-derived ROS have also been implicated in the tissue injury and loss of epithelial barrier 
function associated with clinical disorders resulting from deregulated inflammation (Pfeffer et al,
1994). These pathological roles for the enzyme have attracted greater attention following the 
discovery that corticosteroids and cytokines can regulate the transcriptional activation of the XOR 
gene (Pfeffer et al, 1994). Also of interest is the NADH oxidase activity of XOR, where the 
enzyme-catalysed oxidation of NADH results in the production of superoxide (Sanders et al, 1997). 
As mentioned earlier, NADH is unique in that it donates its electrons to the FAD reactive site and
7
thus this activity would not be blocked by the most commonly-used XOR inhibitors, allopurinol 
and oxypurinol (which inhibit specifically at the molybdenum site). Hence, use of these inhibitors 
as tools to investigate the enzyme’s function may lead to overlooking of the NADH derived ROS.
The production of ROS results in the production of urate (see Fig 1.4), which is in itself a powerful 
antioxidant. It is noteworthy that, whilst for many years ROS have been viewed as harmful 
pollutants, growing evidence is now mounting for their involvement in mediating the gene 
expression in a host of cellular responses including growth, survival and apoptosis (Irani, 2000, 
Hancock et al, 2001). XOR-derived oxygen radicals have also been proposed as potential anti­
cancer therapies. One study has shown that VX2 carcinomas are more susceptible to oxygen 
radicals than the surrounding muscle tissue (Yoshikawa et al, 1995) and, more recently, one group 
has shown the succeful suppression of tumour growth using chemotherapy based on a xanthine 
oxidase-polymer conjugate (Sawa et al, 2000).
1.2.4 Nitric oxide metabolism
The ability of the XOR to produce NO has aroused much interest in recent years. This is a property 
that is, perhaps, not surprising in view of the enzyme’s many similarities with the assimilatory 
nitrate reductases of fungi, algae and higher plants (Hille, 1996). It is of interest because NO is a 
widespread signalling molecule involved in the regulation of an impressive spectrum of diverse 
cellular functions (Kelm et al, 1997).
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The physiological roles of NO include blood pressure regulation, antimicrobial defence and 
neuronal communication (Sampath et al, 1994). This has been reflected in the near exponential 
growth of publications relating to NO and NO synthase (Knowles and Moncada, 1994, Alderton et 
al, 2001). Other functions of NO are as a paracrine messenger, regulation of guanylyl cyclase 
activity, control of neurotransmitter release and acting as a neurotransmitter. NO also has 
bactericidal and tumoricidal activities, may contribute to the biochemistry underlying memory and 
is a mediator of vasodilation acting on smooth muscle cells in the blood vessel wall (Moncada et al, 
1991).
Nitric oxide (NO) synthesis is well-known to result from the oxidation of L-arginine by a family of 
NO synthases (NOS), which requires oxygen. XOR, on the other hand, reduces nitrite to NO under 
anaerobic conditions, and could constitute a complementary system to NOS. Indeed, XOR- 
catalysed production of NO has been shown to fall off as levels of oxygen increase, consistent with 
the concomitant production of superoxide and interaction of the latter with NO to yield 
peroxynitrite (Godber et al, 2000). An NO synthase-independent generation of NO has also been 
demonstrated in rat skeletal muscle after ischemia reperfusion injury (Lepore et al, 1999). The 
XOR-catalysed generation of NO may be important in redistribution of blood flow to ischaemic 
tissue as a supplement to NOS, since both nitrite (Iizuka et al, 1999) and NADH (Harrison, 1997) 
have been shown to be elevated in hypoxic tissue.
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1.2.5 Inactive forms
The ability to purify XOR from milk has allowed insight into the enzyme’s structure, activity and 
kinetics (Godber, 1998). One potentially surprising observation is that up to 60% of XOR, purified 
from bovine milk, is inactive towards conventional reducing substrates such as xanthine (Bray, 
1975). Of this 60%, approximately half lacks the Mo (and potentially the molybdopterin), whilst in 
the other half the Mo=S grouping (essential for catalytic activity) is replaced by Mo=0 (Gutteridge 
et al, 1978). These inactive forms are known as demolybdo-XOR and desulpho-XOR respectively.
Enzyme purified from human milk is up to 95% demolybdo-XOR (Godber et al, 1997). The 
physiologic reason for the production of large amounts of inactive enzyme is unclear, but it is 
possible that the activity of the enzyme may be subject to regulation. Evidence to support this was 
found from study of the activity of XOR in serial samples of human milk taken during the first 
month post partum (Brown et al, 1995). Enzyme activity was observed to peak during the first 15 
days and then to decline by as much as 95% back to basal levels. Protein levels remained constant 
and the variation in activity was attributed to post-translational modification.
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1.3 Properties of human XOR
Reports on the tissue specific activity of XOR vary greatly and are discussed in greater depth later, 
but the consensus would appear to be that, in human tissue, little XOR activity is seen apart from in 
the liver and small intestine (Parks and Granger, 1986). This tissue specific activity, along with the 
variation in activity observed in human milk (Brown et al, 1995) gives the best evidence for the 
support of an alternate physiological role for XOR other than that of the generalised house-keeping 
function of purine catabolism.
One group has reported ‘bovine-level’ activity from a human source that was purified from human 
liver (Krenitsky et al, 1986). However, recent work has given reason to suspect that this may not be 
the case in vivo and that it is more likely to be the result of a purification procedure that selects for 
active forms of the enzyme (Choudhury, 2001).
1.4 Tissue and cellular distribution
Immunolocalisation studies using rabbit anti-bovine milk fat globule membrane antibodies 
demonstrated the presence of XOR in bovine mammary epithelial cells, capillary endothelial cells 
and liver sinusoidal endothelial cells (Jarasch et al, 1981). Subsequent immunolocalisation studies 
have shown the enzyme to be present in human hepatocytes, epithelial cells of the digestive and 
respiratory systems and epithelial cells of lactating mammary gland (Moriwaki et al, 1996). There 
is still some debate as to the presence of XOR in cardiac capillaries and smooth muscles cells 
(Jarasch et al, 1981, De Jong et al, 1990).
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The tissue specific activity of XOR is also a matter of debate. Several groups have demonstrated 
that enzyme activity can only be detected in trace amount in all organs other than the liver and 
small intestine (Kooij et al, 1992, DeJong et al, 1990, Saksela et al, 1998)). A particularly 
contentious issue is that of the presence of XOR activity in the heart. Whilst it is likely that 
circulating XOR is present in the blood flowing through the heart, only one group has reported 
significant enzyme activity in the organ (Wajner and Harkness, 1989) and the difficulty 
experienced in reproducing their results has cast doubt upon them. Indeed, at least one group 
recently detected no XOR protein in heart tissue (Linder et al, 1999).
Also of interest are the reports of localisation and activity of XOR in cancerous tissues and cells. 
Immunocytochemical localisation revealed an absence of XOR in neoplastic breast epithelium, in 
contrast to normal breast epithelium, suggesting that expression of the enzyme is reduced to 
undetectable levels in breast cancer (Cook et al, 1997). Furthermore, XOR activity has been shown 
to be significantly reduced in hepatomas (Pradja et al, 1976, Ikegami et al, 1986), colon carcinomas 
(Weber et al, 1978)) and renal carcinomas (Prajda et al, 1981). Immunohistochemical localisation 
also failed to detect XOR breast cancer cells metastased to the liver (Moriwaki et al, 1996). These 
studies lead to the conclusion that cancerous cells down-regulate the expression and activity of 
XOR. If some understanding could be gained as to why this occurs it may well answer the riddle as 
to the function of the enzyme and simultaneously arm us with a potential therapeutic tool.
The reports of the sub-cellular localization of XOR are perhaps even more confusing, although, as 
with the tissue localisation, there seems to be an emerging pattern. Immunolocalisation of the 
enzyme has shown it to be present on the surface of cultured human (Roquette et al, 1998), bovine 
and porcine (Vickers et al, 1998) endothelial cells and on the luminal side of the plasma membrane 
of rat liver sinusoidal endothelial cells (Frederiks et al, 1999). In contrast to these observations,
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Jarasch and coworkers (1981) observed the enzyme exclusively in the cytosol of bovine endothelial 
cells. Immunogold labeling in conjunction with electron microscopy also showed that XOR was 
exclusively cytosolic in rat hepatocytes (Ichikawa et al, 1992).
Obtaining accurate data on the tissue, cellular and sub-cellular localization of XOR will 
undoubtedly aid greatly in discovering the enzyme’s true physiological function. However, it would 
seem that recent attempts to elucidate this information have only served to muddy the waters. The 
reasons for these apparent discrepancies could be many and undoubtedly include factors such as 
sample source, preparation and immunolocalisation methodology. But probably by far the largest 
contributing factor is the lack of high-affinity and high-specificity antibodies to XOR.
1.5 Proposed pathogenic roles
Generation of ROS by XOR has led to the hypothesis of its involvement in ischemia-reperfusion 
(IR) injury (Granger et al, 1981, McCord, 1985). The key events proposed for this mechanism are 
as follows. During ischemia, cytosolic calcium levels are elevated due to the dissipation of 
transmembrane ion gradients. This results in the activation of proteases that irreversibly convert 
XOR from the XDH form to the XO form. Concurrently, hypoxanthine accumulates from the 
cellular catabolism of ATP. The influx of oxygen on reperfusion causes it to react with XO and 
hypoxanthine resulting in the generation of superoxide and hydrogen peroxide and the subsequent 
production of cytotoxic agents such as hydroxyl radicals (Granger et al, 1981).
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Publication of this hypothesis has resulted in a great deal of debate as to the possibility of this 
mechanism actually occurring in vivo (Wiezorek et al 1994, Frederiks et al, 1993, Kooij et al, 1994, 
Brass, 1995, Kooij et al, 1995, Frederiks and Bosch 1996). Observations in support of the 
hypothesis include attenuation of damage in experimental animals after the administration of 
allopurinol, oxypurinol (both specific XOR inhibitors) or a tungsten rich diet resulting in the 
inactivation of XOR (Kurose and Granger, 1994). However, doubt has been cast upon some of 
these data in view of the hydroxyl scavenging properties of allopurinol and oxypurinol (Moorhouse 
etal, 1987).
ROS are not the only cellular pathogenic agents. NO, has been shown to have a deleterious effect, 
mediated in part by peroxynitrite, on intestinal barrier function (Menconi et al, 1998). As 
previously stated, XOR is a potential source of both these molecules and, in an intestinal model 
using Caco-2 cell monolayers, the breakdown in barrier function could be prevented by the addition 
of allopurinol, an XOR inhibitor (Menconi et al, 1998).
If XOR does have a pathogenic role in vivo, it would seem that there are defences already in place 
to protect the body from damaging effects of circulating XOR. Levels of IgM class anti-human 
XOR antibodies in human serum have been found to be particular high, representing approximately 
3% of total IgM (Benboubetra et al, 1997). The majority of these antibodies appeared as immune 
complexes, suggesting that they were fulfilling a protective role by removing XOR (Benboubetra et 
al, 1997).
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1.6 Normal physiological roles
As previously stated, XOR is best known for its role in purine catabolism. Mutations in the XOR 
gene cause the disease xanthinuria (Rytkonen et al, 1995). Hereditary xanthinuria is a rare 
autosomal recessive disorder in which patients often display renal symptoms because they excrete 
large amounts of xanthine in their urine (Sumi and Wada, 1996). However, the disease is often 
asymptomatic and goes largely undetected.
It has been proposed that XOR may be an anti-microbial agent in the neo-natal gut (Brown et al, 
1995). This idea is supported by the observation that XOR activity in human breast milk shows 
great variation in the first weeks post partum, reaching peak values (as much as 50-fold higher than 
basal levels) usually within the first 10 days, and falling to basal levels thereafter (Brown et al, 
1995). This idea was originally based on the enzyme’s ability to produce ROS, similar to that of 
NADPH oxidase which catalyses the ‘respiratory burst’ in white blood cells. However, not only is 
XOR capable of generating superoxide, it also catalyses the production of NO, a prerequisite for 
peroxynitrite generation (Godber et al, 2000). All of these molecules have potent microbicidal 
effects and it has been known for many years that mammalian milk has antibacterial properties 
(Stevens et al, 2000). In support of this hypothesis is the observation that pathogenic bacteria may 
well bind to epithelial antigens on the milk fat globule membrane in the same manner that they bind 
to similar antigens on the surface of epithelial cells in the digestive track (Keenan and Patton,
1995). This would bring the bacteria into close contact with XOR. Millimolar levels of nitrite 
(DeMoss and Hsu, 1991) produced by the bacteria’s nitrate reductases (Cole, 1996) would provide 
substrates for NO generation and it is noteworthy that the Km value for XOR catalysed nitrite 
production is in the millimolar range (Godber et al, 2000a).
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The localisation of XOR to endothelial cells (Jarasch et al, 1981, Roquette et al, 1998) and its 
ability to produce NO (Godber et al, 2000) has led, as previously stated, to the suggestion that the 
enzyme may be involved in NO-mediated vasodilation. The vasodilatory action of organic nitrates 
has been known for over 150 years and they have been widely used to treat a variety of cardiac 
diseases (Ahlner et al, 1991). However, their mode of action remains unclear (Harrison and Bates, 
1993). XOR has been shown to catalyse the reduction of one such drug, glyceryl trinitrate (GTN), 
to NO in the presence of NAD under hypoxic conditions (Millar et al, 1998). XOR can also 
catalyse the reduction of isosorbide dintrate and isosorbide mononitrate (Doel et al, 2001). Indeed, 
it has been demonstrated that, in the presence of GTN, XOR produces sufficient NO in vitro to 
inhibit platelet aggregation (O’Byme et al, 1999). Whilst the majority of this work centers on 
experimental data gained from purified enzyme, endothelial and smooth muscle cells have also 
been shown to reduce organic nitrates to NO with comparable efficacy (Feelisch and Kelm, 1991).
The administration of these vasodilating drugs results in a phenomenon known as clinical tolerance, 
which is believed to reflect the inactivation of the enzyme(s) responsible for their metabolism 
(Abrams et al, 1998). XOR has also been shown to be inactivated when incubated anaerobically 
with GTN and xanthine (Doel et al, 2001). The ability of XOR to produce NO under hypoxic 
conditions lends itself to the theory that XOR could be an alternative pathway to that of NO 
synthase, as the production of NO from NOS requires oxygen. Interestingly, it has been shown that 
hypoxia up-regulates XOR, although the exact mechanisms of pre and posttranslational synthesis of 
active enzyme remain unclear (Hassoun et al, 1994, Poss et al, 1996).
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The ability of XOR to participate in a broad range of reduction and oxidation activities has led to 
many theories as to its actual function. A greater understanding of the enzyme at a genetic, 
molecular and structural level is needed, along with knowledge of its cellular and sub-cellular 
localisation. It may well be that this intriguing flavoenzyme is merely a partially redundant house 
keeping enzyme, but the current level of interest suggests that there are many who are unwilling to 
accept this as the complete story.
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2 A im s
The aims of this project were to investigate the localization of XOR in various cell types in an 
attempt to gain further understanding of function in vivo. The decision to concentrate on mammary 
and gut epithelial, as well as vascular endothelial cells was based on literature evidence of the likely 
importance of XOR in these cells. Central to many of the results presented is the use of a highly 
specific anti- human XOR antibody, a tool that in previous studies had been unavailable.
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3 M a t e r ia l s
3.1 Chemicals
Bio-Rad protein assay reagent dye concentrate was obtained from Bio-Rad, Hemel 
Hemstead, Hertfordshire. All other chemicals were obtained from Sigma, Poole, 
Dorset, unless otherwise stated.
3.2 Instruments
Centrifugation was carried out in a Beckman TL-100 ultracentrifuge, MSE Centaur 2 
benchtop centrifuge and a Sarstedt microcentrifuge. Sonication was performed using 
an MSE 150Watt ultrasonic disintigrator Mk2. Fluorescent enzyme assays were carried 
out on a Perkin-Elmer LS-5B luminescence spectrophotometer, and absorbance spectra 
on a Cecil CE 6600 multimode computing UV spectrophotometer. Nitric Oxide levels 
were measured using a Sievers 280 nitric oxide analyser. Oxygen levels were 
measured using a MI-730 oxygen microelectrode from Microelectrodes Incorporated. 
Confocal microscopy was carried out on a Zeiss Axiovert 100M confocal microscope, 
and electron microscopy was carried out on a JEOL JEM-1200EX II (JEOL, Tokyo, 
Japan) EM, funded by The Science & Engineering Research Council'. Resin blocks 
were cut on an Ultracut E Ultramicrotome and samples were preserved by slam 
freezing in a Leica EMMM80 Freeze-Slamming Device, both of which were supplied 
by Leica, Wien, Austria.
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3.3 Cell culture
Cell culture was carried out in a microflow culture hood. RPMI 1640 media, 
Dulbecco’s Modified Eagle media, M l99 media, foetal bovine serum, L-glutamine, 
penicillin/streptomycin mixture, cholera toxin, trypsin - EDTA solution, 
hydrocortisone (water soluble), insulin from bovine pancreas, PBS tablets and 
sigmacote, were all obtained from Sigma, Poole, Dorset. Plasticware was obtained 
from Helena Biosciences.
3.4 Cells
HB4a (a conditionally immortalised human mammary luminal epithelial cell line) cells 
were a gift from Dr Kalamati, The Royal Cancer Hospital, Sutton. BRLE (an 
immortalised buffalo rat liver epithelial cell line) cells were a gift from Dr T. Edwards, 
Bath University. EA-hy-926 (a permanent human endothelial cell line) cells were a gift 
from Dr A. George, Hammersmith Hospital, London. ECV-304 (a permanent human 
endothelial cell line) cells were a gift from Dr R. Hurst, University of The West of 
England. Caco-2 (a permanent human gut epithelial cell line) cells were a gift from Dr 
R. Hurst, University of The West of England. CPA (a co-culture of bovine aortic 
endothelial and smooth muscle permanent cell lines) cells were purchased from the 
European Collection of Cell Cultures (ECACC).
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3.5 Antibodies, apoptotic markers and ELISA
Primary anti-human XOR antibody, 1D9/D1 and XOR ELISA kit were developed and 
supplied by Eurogenetics, Belgium. All other primary antibodies, TRITC and FITC 
secondary antibodies and phalloidin-TRITC were obtained from Sigma 
immunochemicals. Secondary gold antibodies were obtained from British Biocell. The 
apoptotic cell marker kit, ApoAlert™ DNA Fragmentation Assay Kit, was obtained 
from Clonetech.
3.6 Electron microscopy reagents
LR White acrylic resin, Epoxy resin (812 Premix Resin Kit) and Gilder Grids (single 
slot, nickel) were all obtained from Taab Laboratories Equipment Ltd., Aldermaston, 
Berks, UK. 50 mesh gold grids, glutaraldehyde 25% in ampoules and 
paraformaldehyde powder were obtained from Agar Scientific, Stansted, Essex, UK. 
The epoxy tissue stain (used for semi-thin sections) comprised a mixture of Toluidine 
Blue O and Basic Fuchsin in aqueous alcohol and was obtained from Electron 
Microscopy Sciences (EMS), Fort Washington, PA, USA.
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4 M e t h o d s
4.1 Routine maintenance of cells
Cells were cultured as monolayers in filter capped tissue culture flasks, at 37°C in a 
humidified incubator with 5% CO2 (v/v) and 95% air (v/v). The cells were provided 
with 0.2ml of medium per cm2, which was discarded every other day and replaced with 
fresh prewarmed medium. In all cases, an aliquot of the medium was placed in the 
incubator to check for contamination prior to culture.
4.1.1 Medium for HB4a cells
RPMI-1640 medium (without L-Glutamine) (500ml) was used and supplemented with 
10% (v/v) foetal bovine serum (FBS) (50ml), 200mM L-Glutamine (7.5ml), penicillin 
(10,000units/ml)/streptomycin (lOmg/ml) solution (10ml), 5pg/ml insulin (0.5ml), 
5pg/ml hydrocortisone (0.5ml) and lOOng/ml cholera toxin (1ml).
4.1.2 Medium for BRLE and Caco-2 cells
Dublecco’s Modified Eagle Media Ml 99 (without L-Glutamine) (500ml) was used and 
supplemented with 10% (v/v) FBS (50ml), 200mM L-Glutamine (7.5ml), penicillin 
(10,000units/ml)/streptomycin (lOmg/ml) solution (10ml).
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4.1.3 Medium for ECV-304 and EA-hv-926 cells
RPMI-1640 medium (without L-Glutamine) (500ml) was used and supplemented with 
10% (v/v) FBS (50ml), 200mM L-Glutamine (7.5ml), penicillin
(10,000units/ml)/streptomycin (lOmg/ml) solution (10ml).
4.1.4 Medium for CPA cells.
Ml 99 medium (without L-Glutamine) (500ml) was used and supplemented with 20% 
(v/v) FBS (100ml), 200mM L-Glutamine (7.5ml), penicillin
(10,000units/ml)/streptomycin (lOmg/ml) solution (10ml).
4.1.5 Establishing cultures from crvopreserved cells
Cell cultures were initially established from cells preserved by freezing in liquid 
nitrogen. Appropriate medium for the cell type was warmed for 30min in a 37°C water 
bath to avoid subjecting the cells to thermal shock. An aliquot of cells stored in a 
cryopreservation vial were removed from the liquid nitrogen and allowed to thaw 
rapidly in the water bath. Once thawed, the cells were pipetted into medium (10ml) in 
a sterile Universal and then centrifuged at 200g for 5min. The supernatant was 
discarded and warmed medium (5ml) was used to resuspend the cell pellet. This was 
then transferred into a flask of equal volume to that in which the cells were originally 
grown. The medium was changed after 24h to remove any remaining DMSO.
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4.1.6 Subculture o f cells
Cells were subcultured shortly before reaching a confluent monolayer. Appropriate 
medium and phosphate buffered saline (PBS) were warmed in a water bath at 37°C to 
avoid subjecting the cells to thermal shock. Medium from the flask was discarded and 
the monolayer of cells was washed twice with warm PBS. After the second wash the 
cells were detached from the flask by trypsinisation, using 0.05% (w/v) trypsin/0.02% 
EDTA (w/v) solution in PBS. BRLE and EA-hy-926 cells started to detach from the 
flask immediately on addition of the trypsin. HB4a and Caco-2 cells were placed in the 
incubator for 5-10min to dislodge them from the surface of the flask. Once all the cells 
were detached from the floor of the flask the reaction was stopped by adding an equal 
volume of medium. An aliquot of the cell suspension was taken and the cell density 
and viability checked using the trypan blue exclusion method. The suspension was 
diluted 1:1 with 0.04% (w/v) trypan blue and the haemocytometer prepared, ensuring 
that Newton's rings of diffraction were visible on the cover slip. The mixture (10pl) 
was loaded into the haemocytometer, being careful not to flood the chamber. The 
number of viable cells (those that do not take up the trypan blue stain) in each of the 
five large squares was counted. If the number of cells counted in 5 squares is n, the cell 
count is:
[ (n/5) x dj] xlO4 cells per ml
where df = dilution factor with trypan blue. If there are too many cells to count or if 
clumping is seen the sample can be diluted further with trypan blue. Once the cell
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viability had been calculated, new tissue culture flasks were seeded at the required cell 
density.
4.1.7 Crvopreservation o f  cells
Cell stocks were preserved by freezing in liquid nitrogen. One flask containing a 
monolayer of confluent cells was trypsinised as described in Section 4.1.6, and 
transferred into a sterile tube.
The cell suspension was centrifuged at 200g for 5min to obtain a cell pellet. The 
supernatant was discarded and the pellet resuspended in FBS (0.5ml). The cells were 
transferred into a cryogenic vial along with appropriate medium (0.4ml) and DMSO 
(lOOpl). The cryogenic tubes were stored at -70°C for 24h before being transferred into 
liquid nitrogen.
4.1.8 Cell harvesting for fluorimetric assay
Cells were grown up for fluorimetric assay as a monolayer in tissue culture flasks as 
described in Section 4.1. They were then removed from the flasks as described in 
Section 4.1.6, and a pellet was obtained by centrifuging the cell suspension at 200g for 
5min. The supernatant was discarded, the inside of tube allowed to air dry and the 
pellet resuspended in fluorimetric buffer (1.2ml). This buffer comprised 50mM 
potassium phosphate (pH 7.4), 0.1 mM EDTA, containing lpg/ml of each of the 
following antiproteinases: pepstatin A, leupeptin, antipain and aproteinin. The
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suspension was then transferred to a 1.5ml Eppendorf tube and kept on ice. The 
Eppendorf was then placed in a cool box to keep cells at a constant temperature and 
sonicated using the 3mm probe for 20s at power setting 6.5. The suspension was then 
ultracentrifuged at 100,000g for 30min at 4°C to give a crude cytosolic fraction that 
was used in both enzyme assays and protein estimations.
4.1.9 Induction o f apoptosis
Apoptosis was induced by the addition of 5mM sodium butyrate to the media, as 
described by Hara et al (2000). Apoptotic morphology (cells rounding up and 
detaching) could be seen 36 -  48h after the addition of the sodium butyrate. Apoptosis 
was confirmed by staining with the TUNEL assay (see Section 4.6.2).
4.2 White blood cell preparation
Blood was collected into heparin (lpl/ml) in polypropylene tubes and diluted 1:1 with 
sterile PBS. This was then layered onto Lymphoprep (specific gravity 1.077g/ml, 
Nycomed) (15ml) in 50ml polypropylene tubes and centrifuged for 30min at 350g. The 
white, cloudy, buffy coat (middle layer) was then harvested directly into RPMI + 10% 
FBS and centrifuged for lOmin at 350g. The medium was removed and the pellet was 
resuspended and washed with warm RPMI. This was repeated several times. This 
method should yield approximately 1 million cells/ml of blood sample. If the sample 
was severely contaminated with platelets, another wash step was performed.
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4.3 Pterin assay for enzyme activity
The sensitive fluorimetric assay described by Beckman et al, (1989), was used to 
assess the activity of XOR. The assay measures the conversion of pterin (2-amino-4- 
hydroxy pteridine) to the fluorescent product isoxanthopterin and utilises 10p,M pterin 
as the reducing substrate and lOpM methylene blue as the oxidising substrate.
All the assays were performed at room temperature in quartz cuvettes using the crude 
cytosolic fraction derived from the cells and cell buffer (made up as described in 
Section 4.1.9) or sonicated whole cells. Fluorescence was measured at an excitation 
wavelength of345nm, an emission wavelength of390nm and with slit widths of 5nm.
A stable baseline was obtained for the cell fraction diluted in fluorimetric buffer. 
10pM pterin and 10pM methylene blue were then added and the reaction rate 
measured over 10-15min. The reaction was stopped by the addition of 50pM 
allopurinol (an inhibitor of XOR activity). Sequential additions of isoxanthopterin 
(4pmol) were added to provide calibration and an internal standard accounting for 
variations caused by fluorescence quenching and scattering. The final reaction rate was 
then calculated as pmol isoxanthopterin/min/mg total protein.
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4.4 Protein estimations
Protein estimations of the crude cytosolic fraction were estimated by using the method 
described by Bradford (1976). The standard used was bovine serum albumin (BSA) at 
a concentration of 0.1 mg/ml.
BSA was diluted in phosphate buffer to a total volume of 1 OOjliI to give concentrations 
ranging from 0 to 10 pg/ml. The crude cytosolic fraction was diluted in phosphate 
buffer to give an approximate concentration that fell within the range of the BSA 
standards. Bio-Rad reagent (1ml) was added to each sample in a plastic cuvette. The 
cuvette was inverted several times and left at room temperature for lOmin for the 
colour to develop. The absorbance at 595nm was measured using a spectrophotometer 
and a standard curve generated from the absorbance readings of the BSA standards. 
This curve was then used to assess the protein content of the crude cytosolic fraction.
4.5 Nitric oxide assay
Nitric oxide assays were carried out on a Sievers 280 nitric oxide analyser. Oxygen 
levels were measured using a Microelectrodes Incorporated MI-730 oxygen 
microelectrode. Oxygen-free nitrogen was passed through the reaction vessel to ensure 
that the reaction remained anaerobic. pH was maintained throughout by a Radiometer 
pH stat. Cells were detached from tissue culture flasks using the mechanical method of 
a cell scraper (there is some concern that trypsin may cleave syndecan bonds that bind 
XOR to the surface of cells), spun down to form a pellet and resuspended in the
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required amount of Hanks buffered saline solution (HBSS). Meanwhile HBSS (pH 7.2) 
containing lOOpM xanthine and lOOmM sodium nitrite was allowed to equilibrate in 
the water-jacketed reaction chamber of the NO analyser until prewarmed to 37°C. 
Once a steady base line was obtained the cells were added and the rate of NO 
production measured. The reaction was stopped by the addition of 50pM allopurinol.
4.6 Confocal microscopy
Confocal microscopy is a powerful tool that allows the reconstruction of high- 
resolution 3D images along with fluorescence labeling and co-localisation.
4.6.1 Preparation o f  cells
Cells were seeded; either from monolayer culture or cryopreservation, onto heat- 
sterilised coverslips or Falcon cell culture inserts placed in six well plates. The density 
of seeding varied and depended on the experiment being performed, although the cells 
were always allowed a minimum of 24h to adhere.
4.6.2 Staining o f cells
Cells grown on coverslips and cells grown on inserts were exposed to the same 
staining protocol. Cells were washed twice in pre-warmed PBS and then fixed in 4%
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(w/v) formaldehyde in PBS for 20min at room temperature. Three more PBS washes 
were performed before permeabilising the cells in 0.1% (v/v) Triton X-100 in PBS for 
30min at room temperature. After anther three PBS washes, the cells were placed in 
blocking buffer [10% (v/v) horse serum, 6% (w/v) bovine serum albumin, made up in 
PBS] at room temperature for lh. A further 6 PBS washes were performed before 
exposing the samples to the primary antibody (see Table 4.1) for 2h. The cells were 
then washed another 6 times in PBS after which, if the primary antibody had no 
fluorescent conjugate, a secondary antibody (diluted 1/200 in blocking buffer) with a 
fluorescent conjugate was applied to the cells at room temperature for lh. A final 6 
PBS washes completed the process. For co-localisation a second primary and 
secondary antibody, with a differently coloured fluorescent tag, was applied in the 
same manner. Once the staining process was completed, the coverslips were mounted, 
cell side down, in a drop of Vectorshield (Vector Laboratories, California, USA) on a 
clean microscope slide. The edges of the coverslip were sealed with clear nail varnish 
and allowed to dry.
Target Name Type Tag? Working dilution
XOR 1D9/D1 Mouse anti-human IgG No 1/1000
Actin Phalloidin Fungal toxin Yes -  red (TRITC) 0.3pM
Apoptotic nuclei TUNEL Chemical labelling Yes - green As supplied protocol
Plasmalema Annexin II Mouse anti-human IgG No 1/5000
Zonula Adherans P-Catenin Mouse anti-human IgG No 1/500
Gap Junctions Connexin-43 Mouse anti-human IgG No 1/250
Focal Contacts Paxillin Mouse anti-human IgG No 1/10,000
Zonula Occludens ZO-1 Mouse anti-human IgG No 1/250
Plasma Membrane VLA-2<x Mouse anti-human IgG No 1/250
Table 4.1: Labels used in cell staining for confocal microscopy.
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4.6.3 Image collection
Sample images were collected on a Zeiss Axiovert 100M confocal microscope. Images 
were taken under oil for both transmitted light and with the appropriate lasers and 
filters for the fluorescent tag. Serial z-sections were taken of some samples, allowing 
the generation of 3D images. Light transmitted and fluorescent images were overlaid 
allowing the fluorescence localisation to be related to the cell monolayer. The 
fluorescent tags used generated either a green colour (FITC) or a red colour (TRITC). 
Where the two overlaid a yellow colour was generated. Prolonged exposure to any 
light source was kept to a minimum to avoid fluorescence quenching of the tag.
4.7 Electron microscopy
Electron microscopy allows high-resolution 2D imaging of cells. Depending on the 
fixing process and the resin used, structures such as the Golgi apparatus, endoplasmic 
reticulum and ribosomes can be seen. Labeling is achieved in a similar fashion to 
confocal microscopy, but a gold tag is used instead of fluorescence, thus avoiding the 
inherent problem of quenching associated with confocal microscopy.
4.7.1 Pre-embeddins labelling
Cells were grown on inserts, as described in Section 4.1.6, until they reached the 
required density. They were initially washed twice in pre-warmed PBS and then fixed
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in 4% (w/v) formaldehyde in PBS for 20min at room temperature. No permeabilisation 
step was performed in an attempt to visualise localization on the cell surface. Three 
more PBS washes were completed after which the cells were placed in blocking buffer 
[10% (v/v) horse serum, 6% (w/v) bovine serum albumin made up in PBS] at room 
temperature for lh. A further 6 PBS washes were performed before exposing the 
samples to the primary antibody for 2h. The cells were then washed a further 6 times in 
PBS after which they were embedded in resin as described in Section 4.7.2. After 
embedding, the cells were labelled with a secondary antibody conjugated to a lOnm 
gold tag.
The secondary antibody was an anti-IgG antibody conjugated to lOnm gold particles. 
The antibody mix was made up at a concentration of 1/50 in blocking buffer and 
polyethylene glycol [10% (v/v) horse serum, 6% (w/v) bovine serum albumin made up 
in PBS] and the samples were incubated, section side down, on a drop of the mix for at 
least 2h.
The samples were then washed 6 times, each wash lasting at least 5min, in TBS as 
previously described. This was followed by a 5min wash in PBS, and then a 2min 
incubation of 2% (v/v) gluteraldehyde in PBS. Finally the grids were washed 6 times, 
5min each wash, in distilled water and dried in warm air.
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4.7.2 Embedding cell samples
Cells were seeded; either from monolayer culture or cryopreservation, onto Falcon cell 
culture inserts (suitable for electron microscopy) placed in six well plates. The density 
of seeding varied and depended on the experiment being performed, although the cells 
were always allowed a minimum of 24h to adhere.
The cells were removed from the medium and three gentle PBS washes were 
completed after which the cells were placed in blocking buffer [10% (v/v) horse 
serum, 6% (w/v) bovine serum albumin made up in PBS] at room temperature for lh. 
A further 6 PBS washes were performed, at which point the samples were treated 
differently according to the resin in which they were to be embedded.
For epoxy resin, the samples were fixed in 2% glutaraldehyde in PBS at room 
temperature for lh. They were then washed 3 times, each wash lasting lOmin, in PBS. 
Cell ultrastructure was then further preserved by incubating the cells in 1% osmium, 
made up in PBS, for 30min at room temperature. This was followed by another three 
lOmin washes in distilled water. The samples were then dehydrated by incubation in 
gradually increasing concentrations of acetone. Initially the samples were submerged 
in 50% acetone for lOmin. This was then removed by aspiration and replaced by fresh 
50% acetone. The process was repeated with 70, 80, 90, 95 and 100% acetone, 
effectively removing all water from the cell samples. Cells were then submerged in a 
1:3 (v/v) epoxy resin and acetone mix and incubated at room temperature for 30min. 
This was poured off and replaced with a 1:1 (v/v) epoxy resin and acetone mix and 
again incubated at room temperature for 30min. The resin mix was removed and
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replaced with pure epoxy resin, in which the samples were allowed to stand for lh, 
after which the resin was replaced with fresh resin and left to stand overnight. 
Complete resin infiltration of the samples was achieved by a further change of resin, 
which was left at room temperature for 6h. The resin was then polymerised by heating 
to 60°C for 24h.
Samples to be embedded in LR White resin were fixed by slam freezing in an attempt 
to avoid the antigenic damage done to the cells by harsher chemical fixing methods. 
However, a weak chemical fixing step was still required, and this was achieved by 
incubating the cells in 4% paraformaldehyde and 0.1% glutaraldehyde, made up in 
PBS, for lh at room temperature. The samples were then given 3 x lOmin washes in 
PBS. The cells were cryoprotected by exposing them to increasing concentrations of 
sucrose. First, they were immersed in 0.5M sucrose for 30min. This was removed and 
successively replaced by 1M sucrose for 30min, then 1.5M sucrose for 45min and 
finally 2M sucrose for lh. Samples were then slam frozen in a Leica EMMM80 freeze- 
slamming device, force setting 1, thickness 2 and speed 1. Once frozen, the samples 
were transferred into methanol that had been allowed to chill in dry ice and incubated 
at -40°C overnight. This was followed by an overnight incubation in 0.5% uranyl 
acetate in methanol at -40°C to further preserve cell ultrastructure. The samples were 
washed 4 times, each wash lasting 2h, in 100% methanol. During the washes the 
temperature was raised from -40°C to -14°C, after which the samples were infiltrated 
with resin. Infiltration was initiated by submerging in the samples in a 1:1 (v/v) mix of 
methanol and LR White resin and incubated, on ice, for lh. This was removed and 
replaced by a 1:2 (v/v) mix of methanol and LR White resin for a further lh. 
Infiltration was achieved by incubating the samples in 100% LR White resin overnight,
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during which the temperature was raised to 0°C. The resin was then polymerised at 
50°C for 24h.
4.7.3 Sectioning
After the samples were embedded in resin, as described in the previous Section, they 
were then sectioned. The resin block was first trimmed with a razor blade under a 
microtome until the filters, upon which the monolayer of cells were grown, could be 
seen. The resin surrounding the filter was trimmed away with a razor to leave a small 
surface area of resin surrounding the filter. This was then sectioned on the microtome, 
using a glass knife, until smooth. Semi-thin sections of approximately 0.5pm were 
taken and floated on a water boat incorporated onto the glass knife. The semi-thin 
sections were then stained with epoxy tissue stain and viewed under a light microscope 
to check that the cells looked healthy (i.e. intact membranes, normal nuclei etc.) and, in 
the case of Caco-2 cells, to look for dome formation.
Once an area of interest had been established, the resin was further trimmed around the 
filter, using a glass knife, until the surface area was reduced as much as possible. Thin 
sections of lOOnm were then floated into a water boat, incorporated on a diamond 
knife, and secured onto either nickel slot grids or gold mesh grids. Once dried, the 
grids were ready for staining and viewing. The grids were prepared for the section by 
Pioloform powder. A solution of 1% pioloform in chloroform was used to coat the 
grids by casting a pioloform film onto a glass slide using a 'Film Casting apparatus' 
and then floating the film off the slide onto the surface of water in a large dish. Grids
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were then dropped matt side down onto the surface of the pioloform film and grids 
plus film were picked up off the water surface with a piece of Parafilm.
4.7.4 Post-embedding labelling
Once on the grids, the samples were ready for labelling via immunocytochemistry. All 
reagents, excepting those containing antibody, were filtered through a 0.22pm filter 
unit to remove impurities.
The first step in this process was to etch the resin away from the samples to achieve 
exposure of antigenic structure. This was accomplished by floating the grids, section 
side down, on a drop of 1% periodic acid for lOmin at room temperature. They were 
then washed by floating them, section side down, in a drop of distilled water for 5min. 
This step was repeated 6 times. The grids were finally floated on a drop of 1% sodium 
metaperiodate for lOmin to complete the etching process. The etching process is not 
necessary for samples embedded in LR White resin and was only performed on 
samples embedded in epoxy resin.
The samples were then washed, as previously described, by floating on a drop of 
distilled water. Again, this step was repeated 6 times, followed by another two 5 
minute washes in TBS (Tris buffered saline). After this, the samples were floated on a 
drop of blocking buffer [10% (v/v) horse serum, 6% (w/v) bovine serum albumin made 
up in PBS] for 30min at room temperature.
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The primary antibody was made up in blocking buffer [10% (v/v) horse serum, 6% 
(w/v) bovine serum albumin made up in PBS] with concentrations of 1D9/D1 (anti- 
XOR antibody) varying from 1/50 to 1/1000 and the control monoclonal anti-Golgi 
apparatus antibody ranging from 1/25 to 1/100. The grids were taken from the 
blocking buffer and floated, section side down, in a drop of the primary antibody mix 
overnight. The samples were then washed twice, as described previously, in TBS for 
lOmin before being returned to blocking buffer for another lOmin.
The secondary antibody was an anti-IgG antibody conjugated to lOnm gold particles. 
The antibody mix was made up at a concentration of 1/50 in blocking buffer and 
polyethylene glycol [10% (v/v) horse serum, 6% (w/v) bovine serum albumin made up 
in PBS] and the samples were incubated, section side down, on a drop of the mix for at 
least 2h.
The samples were then washed 6 times, each wash lasting at least 5min, in TBS as 
previously described. This was followed by a 5min wash in PBS, and then a 2min 
incubation of 2% (v/v) glutaraldehyde in PBS. Finally the grids were washed 6 times, 
5min each wash, in distilled water and dried in warm air.
4.7.5 Staining grids for viewing under a transmission electron microscope
The samples were counterstained to improve contrast when viewed under the electron 
microscope. Firstly the grids were washed several times in distilled water. This was 
then followed by a lOmin incubation in filtered uranyl acetate, conducted in the dark 
due to the photoinstability of the chemical. The grids were washed 5 more times by
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submerging them in distilled water. Counterstaining was completed by incubating the 
samples in filtered lead citrate for 5min. The grids were washed a further 5 times in 
distilled water and then dried using warm air.
4.7.6 Data collection
Images were collected on a JEOL JEM-1200EX II (JEOL, Tokyo, Japan) EM, funded 
by The Science & Engineering Research Council. Photographic records were taken of 
areas of interest along with random samples for statistical analysis.
4.8 Western blot analysis.
The anti-XOR monoclonal antibody, 1D9/D1, was utilised in Western blotting in order 
to localise XOR to cell compartments.
4.8.1 Nuclear preparation
Cells were grown to confluence and then detached from tissue culture flasks using the 
mechanical method of a cell scraper, spun down to form a pellet and resuspended in 
lysis buffer (1.5ml). Lysis buffer comprised lOmM Tris, lOmM NaCl, lOmM MgCh, 
1% (v/v) Triton. The cells were then spun down, for 3min at 3000g in a desktop 
microfuge. The resulting pellet formed a crude nuclear fraction and the supemantant a 
crude cytosolic fraction. The pellet was resuspended in nuclease free water (1ml).
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4.8.2 SDS-PAGE
A 7.5% SDS-PAGE gel was made up as described in Table 4.2. The separating gel was 
flattened by the addition o f water-saturated butanol (20pl) and allowed to set first 
before the stacking gel was poured. The cell fractions were mixed 1:1 (v/v) with 
reducing sample buffer [distilled water (4ml), 0.5M Tris (1ml), glycerol (0.8ml), 10% 
(w/v) SDS (1.6ml), 2-Pmercaptoethanol (0.4ml), 0.05% (w/v) bromophenol blue 
(0.2ml)] together with SDS high colour markers and boiled for 3min to reduce 
disulphide bonds. The gel was immersed in running buffer [Tris base (30g), glycine 
(144g), SDS (lOg) made up to 11 with distilled water, pH 8.3 then diluted 1:10 with 
distilled water] and each sample (25pl) and markers were loaded into the wells. The 
gel was initially run at 100V until the dye front had passed through the stacking gel. 
Then the voltage was increased to 200V and the samples run through until the dye 
front came off the bottom of the gel. At this point the gel was ready for probing by 
Western blot analysis.
Separating Gel (7.5%) Stacking Gel (5%)
Acrylamide 2.5ml 0.67ml
Distilled water 4.85ml 2.7ml
1.5M Tris, pH 8.8 2.5ml -
1M Tris, pH 6.8 - 0.5ml
10% Lauryl sulphate (w/v) lOOpl 40pl
10% Ammonium Persulfate (w/v) 50pl 40pl
TEMED 4pl 4pl
Table 4.2: Recipe fo r SDS stacking and separating gel.
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4.8.3 Western blot
4 Thick filter papers, designed for Western blot transfer, were soaked in transfer buffer 
[Tris (5.8g), glycine (29g), SDS (lg), methanol (200ml), made up to 11 with distilled 
water] and used to form the outside of a sandwich with the SDS gel and a sheet of 
nitrocellulose in the centre. The transfer apparatus was dampened with transfer buffer 
and any air bubbles removed from the stack by the application of gentle pressure. The 
current on the transfer apparatus was set using the following equation:
current (mA) = length o f gel (cm) x width o f gel (cm) x 0.8
The transfer took approximately 2h, the colour markers becoming visible on the 
nitrocellulose membrane when transfer was complete. The nitrocellulose was carefully 
removed from the stack and washed firstly in distilled water and then in TBS. Blocking 
was then achieved by incubation overnight, at 4°C in 2% (w/v) BSA made up in TBS. 
The membrane was then washed in 0.05% (v/v) Tween, made up in TBS. The primary 
anti-XOR monoclonal antibody was made up at a dilution of 1/200 in 1% BSA, 0.05% 
Tween in TBS. Enough of the antibody mix was added to submerge the membrane, 
which was then placed on a shaker at room temperature for 2h.
After incubation with the primary antibody, the membrane was washed 3 times in 
0.05% (v/v) Tween in TBS. The secondary antibody (anti-mouse IgG peroxidase 
conjugate) was made up in the same manner and dilution as the primary antibody and 
enough was added to the membrane to submerge it. The membrane was incubated with
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the secondary antibody on a shaker, at room temperature, for lh and then washed a 
further three times in 0.05% (v/v) Tween in TBS.
Visualisation was achieved by the addition of 4-chloro-naphthal [one tablet dissolved 
in methanol (2ml) and made up to 17ml with TBS]. The blue-black colour developed 
after several minutes and the reaction was stopped by washing the membrane with 
distilled water. The membrane was then allowed to dry.
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5 A c t iv it y  a n d  L o c a l is a t io n  o f  XOR in  E n d o t h e l ia l  C e l l s
Endothelial cells are cells that line blood and lymphatic vessels. Nitric oxide is 
continuously produced by these cells for the purpose of vascular homeostasis, 
including modulation of vascular tone. Previous work has indicated a role for XOR in 
the reduction of inorganic and organic nitrates and nitrites (Godber et al, 2000a, Doel 
et al, 2000; 2001) and it was with this in mind, coupled with the observation that 
endothelial cells can also reduce organic nitrates to NO (Feelisch and Kelm, 1991), 
that it was decided to investigate the localisation and activity of XOR in endothelial 
cells.
Two cell lines, EA-hy-926 and ECV-304, were used as models. EA-hy-926 is a 
permanent endothelial cell line created by hybridisation of human umbilical vein 
endothelial cells (HUVEC) with a permanent cell line derived from a human lung 
carcinoma (A549), whereas ECV-304 spontaneously immortalised. There is some 
controversy over which is the better model, or if indeed either truly represents 
endothelial cells. However, recent work has demonstrated that, whilst ECV-304 may 
not be ideal, it is still an appropriate choice for the study of endothelial cells (Tan et 
al, 2001). EA-hy-926 cells, for their part, have been shown to display at least one 
highly differentiated function of vascular endothelium, factor VUI-related antigen, 
with the same morphological distribution as primary endothelial cells (Edgell et al, 
1983). In this project, both cell lines were used in order to allow comparisons between 
the two and to minimise artifacts caused by using individual cell lines.
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5.1 Growth curve and pterin-dependent XOR activity
EA-hy-926 cells were seeded at the same density in multiple flasks and, as described 
in Section 4.1, harvested at set intervals for fluorimetric assay. Assays were 
performed on samples from three flasks and all assays were done in duplicate. The 
pterin assay was performed, as described in Section 4.3, with appropriate controls.
The growth curve for pterin-dependent XOR activity versus cell number is shown in 
Fig 5.1. XOR activity only appears on day 11, after the cells have reached confluence. 
It rises to plateau values by day 13 and maintains these levels until day 17 when it 
rises to a further peak. At this point, cells are starting to overgrow and detach and 
many more non-viable cells are seen, presumably because of overcrowding, 
acidification of the growth media and competition for resources. The peak in XOR 
activity under these circumstances could imply that the enzyme has a role to play in 
the apoptotic pathway.
Similar data were obtained for the ECV-304 cell line (data not shown). However, the 
activity of these cells frequently borders on the lowest level of detection of the pterin 
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Fig 5.1: Changes in cell count and XOR activity over a time course o f 20 days
5.2 Nitric oxide generation
Nitric oxide levels were measured as stated in Section 4.5. However, results were 
unpredictable and difficult to reproduce. Xanthine, hypoxanthine and NADH were all 
used as electron donors, along with various combinations of inorganic and organic 
nitrates and nitrites in attempts to optimise the assay. Fig 5.2 shows NO generation 
observed with EA-hy-926 cells in the presence o f lOOpM xanthine and lOOmM 
sodium nitrite. The pH was maintained at 7.2, using a pH stat to avoid the 
















more predictable, an XOR inhibitor would have been added at the end of the assay, 
but this was made difficult by the lack o f reproducibility of the data. The only 
evidence that XOR is the enzyme responsible for this NO production is the 
observation that NO was not detected in the absence of XOR substrates.
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Fig 5.2: NO production from the endothelial cell line EA-hy-926. Buffer containing 100/jM  xanthine 
and lOOmM sodium nitrite was allowed to equilibrate in the reaction chamber for several minutes. The 
reaction was started (indicated by a red arrow) by the addition o f between 106 and 206 cells that had 
been pelleted, washed and resuspended in reaction buffer (I ml) .
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5.3 Localisation of XOR in endothelial cells by electron microscopy
Electron microscopy was carried out as detailed in Section 4.7. All ‘secondary 
antibody only’ controls show very low levels of non-specific staining. Cells were 
either embedded in epoxy or LR White resin and samples were preserved either 
chemically or by slam freezing.
5.3.1 Cell morphology
Cells were observed at approximately 80% confluence. EA-hy-926 cells grew as a 
monolayer, with some cells ‘piling’ up and appearing cuboidal, as seen in Fig 5.3. 
Limited microvilli could also be seen.
No good sections of ECV-304 cells were obtained. Despite repeated attempts to 
optimise the protocol, the cells were sparse and showed few of the signs of ‘healthy’ 
cells, such as Golgi apparatus, mitochondria and vesicular activity. Therefore, the 
electron microscopy results in this Chapter are from EA-hy-926 cells only.
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5.3.2 Localisation o f XOR in cells embedded in LR White resin
LR White resin often gives better levels of labelling than does epoxy resin, because it 
can be polymerised by heat or UV light, whereas epoxy resin can only be polymerised 
by heat. Also, LR White sections are hydrophilic, resulting in better penetration of 
probes into the sample, with superior results for post-embedding immunogold 
labelling (Hayat, 1989). LR White resin also lends itself to fixing of the sample by 
slam freezing. This combination was shown to give the best results with EA-hy-926 
cells, although the cell ultrastructure is less well preserved than for samples embedded 
in epoxy resin.
XOR labelling could be seen in defined areas of the cell and in certain organelles. 
Figs 5.4 and 5.5 show packets of gold, potentially indicating vesicular transport of the 
enzyme. The nuclear membrane is also labelled, suggesting that the enzyme is either 
bound to the inside of the membrane itself or attached to nuclear pores. The labelling 
is particularly hard to see in Fig 5.4 due to the low magnification, but it gives an 
indication of the distribution of the clusters of gold.
The edges of two neighbouring cells can be seen in Fig 5.6. This concentration of 
XOR, in the area where two cells abut, was frequently observed and is supported by 
the later confocal localisation.
Statistical analysis of the labelling (see Appendix) showed high levels of staining in 
the area where cells abut. High levels of gold were also seen clustered in small 
‘packets’. Very little of the labelling appeared to be solely cytosolic.
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Fig 5.3 : This image shows a low magnification overview o f EA-hy-926 cells. The green arrow indicates 
the film the cells are grown upon. Three whole cells can be seen in this image. Cells 2 and 3 display 
microvilli on their apical surface, unlike cell 1. The ultrastructure is poor due to the method o f fixing 
used on samples embedded in LR White resin. No gold labelling can be seen at this magnification. 
(Magnification x6000).
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Fig 5.4 and 5.5: Gold labelling in 'packets ’ and within the nuclear membrane in LR White embedded 
endothelial cells. The nuclear membrane is highlighted in several places in each image with green 
arrows and the nucleus itself indicated by a star. To make the clusters o f gold in Fig 5.4 easier to 
identify a red circle indicates them. The gold labelling can clearly be seen in Fig 5.5 as near perfectly 
spherical black dots. There appears to be some localisation with a membrane, shown by a #, but the 
quality o f the ultrastructure makes it impossible to tell what organelle, i f  any, this is. (Magnification 
x30,000 andx75,000 respectively)
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Fig 5.6: Localisation o f XOR in two neighbouring endothelial cells. The gap between the cells shows 
up on the image as white with a few microvilli reaching into the space. The cells are numbered I and 2 
with the gold being highlighted by red circles. (Magnification x25,000)
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5.3.3 Localisation o f XOR in cells embedded in epoxy resin
Low levels of staining were observed when compared to the levels of staining seen in 
LR White embedded samples. Although staining levels were low, the results were 
reproducible and seemed independent of the etching process used. It is not unexpected 
to obtain lower levels of staining in epoxy resin. However, provided that the staining 
correlates with that seen in LR White resin, epoxy resin can be useful in aiding 
localisation because of the higher quality of ultrastructure achieved. Both the lower 
levels of labelling and the higher quality of the ultrastructure are a reflection of the 
polymerisation and fixing procedures used in conjunction with epoxy resin. In all the 
images referred to in this Section, a purple arrow highlights the gold labelling as the 
low abundance of labelling makes it less easy to recognise.
Fig 5.7 clearly shows localisation of XOR to the inside of a vesicle near the apical 
surface of an endothelial cell. The clarity of the image leaves little room for doubt and 
supports the localisation in LR White resin. Furthermore, in Fig 5.8 the enzyme can 
be seen within the Golgi apparatus and associated vesicles. This result was 
particularly convincing as labelling was seen in this specific organelle on several 
serial sections, making the probability that it was non-specific labelling very unlikely.
The nuclear staining seen in the previous Section is further verified by the localisation 
seen in Fig 5.9. In this image a cluster of gold can be seen at the nuclear membrane 
and, once again, it would seem to be lodged in a nuclear pore. Fig 5.10 is an image of 
two abutting cells. Despite the low levels of labelling seen using this technique, the
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Fig 5.7: Localisation o f  XOR to a vesicle near the 
basal surface o f an endothelial cell. The 
gold can clearly be seen as black spheres in close 
proximity to the vesicular membrane.
(Magnification x75,000)
Fig 5.9 : XOR is shown to be localised to 
the nuclear membrane. A black arrow indicates 
the nucleus. (Magnification x75,000)
Fig 5.8: Labelling for XOR within the Golgi 
apparatus and associated vesicles o f  an 
endothelial cell. The bulbous Golgi cisterne are 
seen close to the nucleus, just visible in the 
bottom right and denoted by a star.
(Magnification x40,000)
Fig 5.10: Localisation o f XOR in the periphery o f  
neighbouring cells. The area between the 
cells shows as white with microvilli intruding 
from each cell. (Magnification x40,000)
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labelling was noticeably higher in these areas, once again supporting observations 
from the previous Section.
The results from cell samples embedded in epoxy resin supported all those obtained 
for samples embedded in LR White resin. This is a strong indication that the labelling 
is specific and not an artefact of experimental protocol.
5.3.4 Controls
Two staining controls were used (see Appendix for results). For each batch of staining 
a ‘secondary only’ control was performed, where secondary antibody (lOnm gold 
conjugate) was added, but no primary antibody was used. This demonstrated no non­
specific binding of the secondary antibody. In all samples this was negligible.
A monoclonal IgG antibody to the peripheral Golgi membrane 58kD protein was used 
as another control. While this monoclonal could clearly be seen to label the Golgi 
apparatus, its staining pattern differed completely from those of 1D9/D1. This 
demonstrated that the staining seen by the 1D9/D1 monoclonal IgG antibody was 
specific and not non-specific binding of binding of this isotype of antibody.
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5.4 Localisation bv confocal microscopy
Staining was carried out as described in Section 4.6. The results were consistent and 
reproducible, with all negative controls showing very little non-specific staining (see 
Appendix). It was found that fixing with paraformaldehyde caused a degree of 
permeabilisation. Therefore all data shown are from permeabilised cells.
5.4.1 Localisation o f XOR in primary and permanent endothelial cells
Staining in permanent and primary endothelial cells showed a consistent pattern. Fig
5.11 shows the punctate staining seen routinely in the cells before they reach 
confluence (shown in the permanent cell line ECV-304). The staining was broadly 
cytosolic with some concentration seen where cells abut. A similar pattern was seen in 
human umbilical vein endothelial cells (HUVECs), as shown in Fig 5.12, although the 
staining is less punctate and does not extend to the very edge of the cells.
Figs 5.13 and 5.14 demonstrate an alternative localisation pattern occasionally seen in 
sub-confluent cells. Here, much larger punctate staining was seen which seems to be 
associated with a putative vesicle or membrane-bound body, which can be observed in 
the light-transmitted image (some of these structures can be seen unlabelled in the 
overlay, Fig 5.13). This pattern of staining was seen less frequently to that mentioned 
previously and its occurrence appeared to be random. Attempts to find the conditions 
required to promote this phenomenon were unsuccessful (cells were grown in the
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Fig 5.11: Localisation o f XOR in two ECV-304 
cells. The boundary between the cells is shown 
by a red arrow and punctate staining extends 
to the periphery o f  the cells.
Fig 5.12: Localisation o f XOR in HUVECs.
The nuclei appear free o f fluorescence (red arrows) 
with the concentration o f staining being 
perinuclear. Unstained cell process ’ are shown 
by a blue arrow.
Fig 5.13: Localisation o f XOR in ECV-304 cells. 
Nuclei are indicated by red arrows and the 
cytosol can be seen as faint ‘dimpling ’ 
around the nucleus.
Fig 5.14: Localisation o f XOR in ECV-304 cells. 
One cell in this image shows the larger punctate 
staining. Again the nucleus is indicated by a red 
arrow.
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presence of XOR inhibitors, calcium ionophores, molybdenum trioxide as well as 
being incubated at 4°C before staining).
Confluent and post-confluent cells show less punctate staining. Nuclear staining was 
seen on many occasions, as shown in Fig 5.15. When present, the staining in the 
nucleus was more intense than any cytosolic staining seen in the same sample. 
Nucleosomes were always visible as unstained portions of the nucleus. Nuclear 
staining as also seen in sub-confluent cells, but seldom with te intensity and frequency 
of that seen in confluent and post-confluent cells. To eliminate the possibility of non­
specific staining in the nucleus, a nuclear preparation of post confluent cells was 
subjected to Western blot analysis (as described in Section 5.8). This confirmed the 
presence of XOR in the nucleus (results not shown because of difficulties encountered 
scanning the blots).
5.4.2 Localisation o f XOR in barrier-positive and barrier-negative endothelial cells
ECV-304 cells grown on cell culture inserts were provided, ready fixed, by Dr Roger 
Hurst from the University of the West of England, Bristol. The endothelial cells were 
grown in co-culture with a monolayer of glial cells. Endothelial cells grown in this 
manner form tight junctional complexes, and develop a permeability barrier having a 
high transcellular electrical resistance (Hurst and Fritz, 1996). Both barrier-positive 
(grown in co-culture with glial cells) and barrier-negative (grown in the absence of 
glial cells) samples were provided. Localisation of XOR was carried out as described 
in Section 4.6.
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Fig 5.15: Localisation o f XOR in post confluent EA-hy-926 cells. Intense staining can be seen in the 
nucleus, an example o f which is indicated by a red arrow. The nucleosomes are devoid offluorescence 
and are indicated in the example by white arrows. The quality o f the transmitted light image makes it 
difficult to identify the edges o f the cells.
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Figs 5.16 and 5.17 show the localisation seen in barrier-positive samples. Again, 
intense nuclear staining was seen with an absence of staining in the nucleosomes. This 
was accompanied by punctate cytosolic staining that was much less intense. This 
pattern of staining is similar to that shown previously in post-confluent endothelial 
cells (see Fig 5.15).
A similar pattern of staining was seen in barrier-negative cells, except that the staining 
was weaker and the nucleosomes were less pronounced, (Figs 5.18, 5.19).
5.4.3 Localisation o f XOR in apoptotic endothelial cells
Previous work (Holt 2000) had shown intense XOR staining in apoptotic cells. The 
staining appeared to co-localise with TUNEL staining (Holt 2000). This work was 
reinvestigated and the cells were driven into apoptosis as described in Section 4.1.9. 
Fig 5.20 shows XOR localisation (red) in EA-hy-926 cells driven into apoptosis by 
sodium butyrate. The cells were also stained with TUNEL (green). It can be seen that, 
whilst XOR is present in these cells, it does not seem to exhibit a different staining 
pattern to that observed in normal confluent cells, except that there appears to be less 
staining for XOR. There was some concern that the TUNEL labelling may have 
interfered with the detection of XOR, as cells treated in the same manner but not 
subjected to TUNEL labelling, showed comparable levels of XOR to those seen 
previously (see Section 5.4.1). There is no co-localisation between XOR and TUNEL.
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Fig 5.16 and 5.17: Localisation o f XOR in barrier-positive ECV-304 cells. Nuclei show up as areas o f  
more intense staining with the nucleosomes devoid o f staining.
Fig 5.18 and 5.19: Localisation o f XOR in barrier-negative ECV-304 cells. Individual cells are more 
difficult to identify, as less nuclear staining is present. In Fig 5.19 slightly more nuclear staining is 
seen and the greater magnification allows three individual cells to be identified.
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Fig 5.20: Localisation o f XOR (red) and TUNEL 
(green) in apoptotic EA-hy-926 cells. The TUNEL 
stain makes the nuclei o f apoptotic cells appear 
bright green.
Fig 5.21: Localisation o f  XOR in CPA cells. 
Two endothelial cell processes are shown by 
red arrows and a smooth muscle cell by a white 
arrow. The blue arrow indicates an endothelial 
cell process approaching another endothelial 
cell.
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5.4.4 Localisation o f XOR in CPA co-culture
CPA cells are a co-culture of bovine aortic endothelial and smooth muscle cells. XOR 
was localised as described in Section 4.6. XOR can be seen in the processes of 
endothelial cells (highlighted in Fig 5.21 by red arrows) directed towards smooth 
muscle cells (highlighted in Fig 5.21 by a white arrow).
5.4.5 Localisation o f XOR and actin
ECV-304 and EA-hy-926 cells were probed with a monoclonal antibody against 
XOR, as described in Section 4.62. They were then stained with phalloidin toxin, 
which binds to actin, as described in Section 4.63.
ECV-304 cells are shown in Figs 5.22 and 5.23. EA-hy-926 cells are shown in Figs 
5.24 - 5.26. In both cell lines, the staining is very similar. Once again, clear punctate 
staining can be seen. This appears to be particularly concentrated in the nuclear and/or 
perinuclear region. Actin filaments can be clearly seen but no co-localisation between 
actin and XOR is evident.
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Fig 5.22 and 5.23: Co-localisation o f XOR (green) and actin (red) in ECV-304 cells.
Fig 5.24, 5.25 and 5.26: Co-localisation o f XOR (green) and actin (red) in EA-hy-926 cells. In all the 
images on this page the actin can be seen as long red filaments within the cell and marking the edge o f  
each cell. XOR staining appears as punctate nuclear and/or perinuclear staining.
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5.5 Discussion
Levels of XOR activity, detected by the pterin assay (Beckman et al, 1989), as 
described in Section 4.3, were low for the EA-hy-926 cell line and on the limit of 
detection for the ECV-304 cell line. However, the growth curve (Fig 5.1) shows a 
clear trend in activity of XOR with cell numbers. The initial plateau of activity 
corresponds with the cells’ becoming confluent. It is possible that XOR-derived ROS 
facilitate cell-to-cell signalling as the monolayer is formed (Rouquette et al, 1998).
The second plateau of pterin-dependent XOR activity is seen as the cell numbers 
further increase (Fig 5.1), causing crowding, competition for resources and cell death, 
as judged by permeability to Trypan Blue. The ROS produced by XOR may have 
another role to play at this stage, in the apoptotic pathway (Hancock et al, 2001).
NO production from EA-hy-926 and ECV-304 cells was measured as described in 
Section 4.5. It is well documented that NO can be produced from the acidification of 
nitrites, as shown in the equations below (Weitzberg and Lundberg, 1998). As cells 
constantly produce acid in anoxic conditions, it was important to maintain constant 
pH levels within the reaction. This was achieved by the use of a pH stat.
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2HN02 ^ N20 3 + H20
n 2o 3 n n o + n o 2
2N0 + 0 2 --------> 2N02
NO production could be demonstrated, but not consistently. While Fig 5.2 represents 
one positive result, several runs were negative or inconclusive. The only evidence that 
XOR was responsible for the production of NO was the observation that apparent NO 
production was dependent on XOR substrates. Use of XOR inhibitors was 
complicated by pH effects, in that all those available need to be dissolved in NaOH. 
The pH stat can only compensate in one direction and was unable to deal with the 
addition of NaOH as it was programmed to compensate for the production of acid by 
the cells. The anoxic state of the reaction vessel should rule out the production of NO 
by NOS, as NOS requires oxygen as a substrate.
The lack of reproducibility of the data probably reflects the complications of running 
an assay with a whole cell system. The physiological state of the cells could be altered 
by something as simple as mechanical shock, e.g. knocking the flask in which they 
were growing. Also the amount of free radical scavengers within the cells was an 
unknown commodity.
It is likely that one of the reasons that XOR-derived NO was so difficult to detect was 
the intrinsically low level of XOR activity within these cells (Fig 5.1). Currently, the 
only way to circumvent this problem would be to use a cell line that had been
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engineered to express more active XOR. This is, however, not only difficult and time 
consuming, but introduces further uncertainties regarding the relevance of observed 
data to normal cells.
The localisation of XOR via electron microscopy showed a consistent pattern of 
labelling, despite wide variation in experimental protocols. Such changes included 
varying the preservation of the cells (both chemical preservation and cryopreservation 
were used), varying the resin and conditions for its polymerisation, and using different 
concentrations of both primary and secondary antibodies. However, the levels of 
labelling remained relatively low. This could reflect the use of a monoclonal antibody, 
which, unlike polyclonal antibodies, recognises a single epitope. Fewer relevant sites 
are accordingly available and the signal is correspondingly weaker (Lin et al, 1983).
Higher levels of gold labelling were observed in cells embedded in LR White samples 
rather than in epoxy resin. This is a common phenomenon and is a result of the fixing 
and polymerisation methods that are used in the different resins. The two resins are 
often used in conjunction as, whereas LR White resin gives higher levels of labelling, 
it is at the cost of poorly preserved ultrastructure. In epoxy resin, the membrane 
components of the cells show far better preservation.
The labelling seen via electron microscopy gave some evidence of vesicular transport 
of the enzyme. XOR appeared to be localised in discrete ‘circles’ at high 
magnification and in ‘packets’ or ‘bundles’ at lower magnification. This was 
confirmed by samples embedded in epoxy resin, where the higher quality of 
ultrastructure allowed the visualisation of labelling within a vesicle. By means of the
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same protocol the enzyme was localised to the Golgi apparatus and associated 
vesicles. XOR also showed consistent localisation with either the nuclear membrane 
or the nuclear pore, suggesting a cell signalling function.
Statistical analysis (see Appendix) of the labelling showed high levels of XOR in the 
areas where neighbouring cells abut. This phenomenon has been observed previously 
(Rouquette et al, 1998) and supports an intercellular signalling role for the enzyme. A 
high association with small ‘packets’, shown by epoxy resin-embedded samples to 
resemble vesicles, was also statistically shown.
In confocal microscopy, XOR showed discrete punctate staining (see Fig 5.11). On 
several occasions, particularly large vesicle-like structures could be seen on the light- 
transmitted image that co-localised with the fluorescent labelling for XOR (see Figs 
5.13, 5.14). This pattern of labelling was observed in both ECV-304 and EA-hy-926 
cells. Attempts were made to define the conditions needed to produce this 
localisation, but despite the use of ionophores, molybdenum trioxide, XOR inhibitors 
and additional FBS in the media, the cause of the production these large vesicular 
structures could not be ascertained and the pattern of localisation could not be 
reproduced systematically.
It is possible that, under certain conditions, XOR localises to endosomes and previous 
work, using Lucifer Yellow as a fluid phase marker (Holt, 2000) did indeed show a 
degree of co-localisation. Nevertheless, not all the structures labelled for XOR 
appeared to be endosomes. ELISA of the media showed that it contained low levels of 
XOR (<0.6ng/ml) (Igor Bondarenko, personnel communication), and it is possible
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that the cells were endocytosing small quantities of the enzyme. However, this is 
unlikely to account for all the labelling. In an attempt to clarify this issue, labelling of 
live cells was attempted. It was hoped that incubation at 37°C or 4°C would show 
differential labelling, reflecting endocytosis or none, respectively. However, no 
labelling was observed at either temperature (data not shown), most probably because 
the monoclonal antibody epitope was not accessible in un-fixed cells. One hypothesis 
for the labelling of these large vesicular like structures is that they act as a storage 
facility for XOR and, when the cells are subjected to a certain stimulus, the XOR is 
released and the more reproducible, smaller punctate staining is seen.
The smaller punctate staining pattern was far more consistent. It was seen in all 
samples and all endothelial cells examined, including primary HUVEC’s (see Figs
5.11 - 5.14). That this represented vesicular localisation was supported by electron 
microscopy. The intensity of the staining is higher where cells meet, suggested 
transport to the cell surface or even to the junction between neighbouring cells. 
Previous work has shown XOR to be localised on the outer surface of endothelial 
cells (Rouquette et al, 1998) but attempts to demonstrate this were unsuccessful, 
largely because of the fact that the fixing process also permeabilised the cells. The 
concentration of paraformaldehyde was lowered, as was the temperature at which the 
cells were fixed, but still antibody was able to gain access to the cytosol.
A high level of labelling for XOR was observed in the nuclei of post-confluent cells 
(Fig 5.15). Whilst nuclear labelling was evident in sub-confluent cells, it was seldom 
as intense as that seen in post-confluent cells. Nuclear staining could be distinguished 
from intense perinuclear staining by the presence of obvious nucleosomes and by the
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microscopes’ ability to image the cell in 3D. When a cell nucleus is stained it appears 
as the yolk in an egg when thin slices are taken. In the upper sections the staining is 
not visible, but as the focal plane moves down, the nucleus begins to appear. Cells 
displaying this staining were at the same density as those at the end of the growth 
curve (Fig 5.1, days 17-20). It is possible that the nuclear staining reflects induction of 
the apoptotic pathway, initiated as the cells become crowded and competition for 
resources increases. This was fiirther explored by driving the cells into apoptosis by 
addition of sodium butyrate, and then measuring XOR activity via the pterin assay. 
However, levels of XOR activity within these cells are on the lower limit of detection 
of the pterin assay and the results proved inconclusive.
Barrier-positive is the shorthand for endothelial cells grown in co-culture with glial 
cells; barrier-negative cells have not been grown in co-culture. This method of 
inducing endothelial cells to form tight junction complexes and develop permeability 
barriers was designed as a model for investigating the blood-brain barrier (BBB) 
(Hurst and Fritz, 1996). It has previously been shown that the BBB model is sensitive 
to oxidative stress (Hurst et al, 1998) and, given the ability of XOR to produce ROS 
(Sussman and Bulkley, 1990), it seemed appropriate to investigate the localisation of 
XOR in these endothelial cells. The only recognisable difference between barrier- 
positive and barrier-negative cells was a less intense nuclear staining in the latter. It is 
unclear if this difference is caused by the presence of a permeability barrier in the 
cells grown in co-culture with glial cells, or if it is merely a reflection of how 
confluent the cells were. It proved difficult to determine the precise cell density before 
labelling as the matrix upon which the cells were grown made identification of single
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cells difficult. Whilst individual cells that had been labelled can be seen, it is difficult 
to judge if any cells have been dislodged by the fixing and staining process.
In order to investigate further the possibility that XOR is involved in the apoptotic 
pathway, apoptotic cells were stained for both XOR and TUNEL. TUNEL staining 
labels fragmented DNA and is an early marker of apoptosis. Cells driven into 
apoptosis by sodium butyrate did not demonstrate elevated levels of labelling for 
XOR, nor did the labelling co-localise with TUNEL (see Fig 5.20), once again 
providing no conclusive evidence as to the enzymes involvement in the apoptotic 
pathway.
As mentioned previously, a potential function of XOR in endothelial cells would be to 
facilitate vasodilation by the production of NO. NO works as a paracrine messenger 
that is released from endothelial cells and acts on smooth muscle cells (Moncada et al, 
1991). With this in mind, the localisation of XOR was studied, by means of confocal 
microscopy, in CPA cells. CPA cells are commercially available from the European 
Collection of Cell Cultures (ECACC) and comprise a mixture of bovine aortic 
endothelial and smooth muscle cells. The smooth muscle cells appear as large and 
striated (see Fig 5.21, white arrow), whereas the endothelial cells are small and 
triangular. The red arrows in Fig 5.21 indicate processes reaching out from the 
endothelial cells towards a smooth muscle cell. These processes show relatively high 
levels of XOR labelling, along with the usual punctate staining that can be seen in 
both cell types. Thus XOR does appear to be localised in specific areas of endothelial 
cells directed towards smooth muscles cells, as expected for an enzyme producing a 
paracrine messenger. The blue arrow indicates a process from one endothelial cell
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approaching another endothelial cell. This suggests that the enzyme is signalling not 
just to the smooth muscle cells, but also to cells of its own kind.
XOR localisation was performed in conjunction with actin labelling in both ECV-304 
and EA-hy-926 cells. The question was asked as to whether the punctate labelling for 
XOR would be seen to co-localise with actin, consistent with vesicular movement of 
the enzyme along the cytoskeleton. However, whereas punctate staining can be seen 
in all the samples (see Figs 5.22 - 5.26), no co-localisation with actin can be seen. The 
majority of the XOR labelling appears to be in the nuclear and/or perinuclear region. 
This does not rule out vesicular transport of the enzyme to the cell periphery, but it 
does eliminate cytoskeletal-facilitated vesicular transport.
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6 A c t i v i t y  a n d  L o c a l i s a t i o n  o f  XOR
in  M a m m a r y  E p it h e l ia l  C e l l s
There is increasing evidence for a physiological role for XOR in human breast milk. 
XOR is a major protein component of the milk fat globule membrane (Patton and 
Keenan, 1975) and the enzyme appears to have an increased specific activity for 
approximately 3 weeks post partum (Brown et al, 1995). In this Chapter the 
localisation and activity of XOR in mammary epithelial cells was investigated in 
order to clarify the enzyme’s function within these cells.
6.1 Growth curve and pterin-dependent XOR activity
HB4a cells are a conditionally-immortalised (SV40) human mammary epithelial cell 
line, showing low levels of XOR activity. Cells were seeded at the same density in 
multiple flasks and, as described in Section 4.1, harvested at set intervals for the 
fluorimetric pterin assay. The cell number and pterin-dependent XOR activity were 
monitored from cells seeded at low density up until post-confluence, where the cell 
culture became unviable. Assays were performed on samples from three flasks and all 
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Fig 6.1: Changes in cell count and XOR activity over a time course o f 20 days
A peak in XOR activity can be seen shortly after the cells reach confluence on day 
10. However, the activity of the cells seemed dependent on the addition o f fresh 
medium. Activity clearly falls when the medium is exhausted and in need o f changing 
(every odd numbered day). Overall, the assays were not very satisfactory in that the 
low levels o f activity were at the limit o f detection o f the pterin assay. Attempts to 
improve matters by increasing the sample size resulted in increased light scattering 
and noise, making calibration difficult.
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6.2 Nitric oxide activity
NO assays were carried out as stated in Section 4.5. Despite numerous attempts under 
different conditions, no NO was detected from this cell line. HB4a cells show veiy 
low levels of XOR activity and it is possible that this, along with the inherent 
problems of using a whole cell system, resulted in the failure to detect NO production. 
The cells were still viable at the end of the 30 min assays, as ascertained by the 
Trypan Blue exclusion test. When the cells were transferred back into a flask at the 
end of the assay they continued to multiply and display normal cell morphology, 
indicating that the inability to detect activity was not a result of cell death during the 
assay.
6.3 Localisation of XOR bv electron microscopy
Electron microscopy was carried out as detailed in Section 4.7. Using samples 
embedded in both LR White and epoxy resin. As noted in Chapter 5, the procedures 
used for fixing and embedding cells in LR White resin and epoxy resin result in 




HMa cells were observed at approximately 80% confluence. They grew as a 
monolayer and appeared elongated and cuboidal with a small number of microvilli on 
the surface, as seen in Figs 6.2 and 6.3.
6.3.2 Localisation o f XOR in cells embedded in LR White resin
The images referred to in this Section were all fixed by freeze slamming.
Whereas the procedures used resulted in poorer visible ultrastructure than that 
observed in epoxy resin embedded samples, labelling for XOR could nevertheless be 
pinpointed to areas within the cells. Clear ‘packets’ of gold could be seen, as 
demonstrated in Figs 6.4 and 6.5, and there was often higher concentration of these 
clusters in the apical area of the cell. The uppermost gold packet in Fig 6.5 seems to 
show localisation to a membrane, seen in the image as a stripe slightly lighter in 
colour than the main body of the cell. It is possible that this could reflect association 
with the Golgi apparatus or endoplasmic reticulum. Such a conclusion could not, 
however, be based on this image alone.
More ‘packets’ of gold can be seen in Fig 6.6, along with an unlabelled 
mitochondrion. No mitochondrial staining was observed in any of the cells studied, 
ruling out any possible function for XOR within this organelle.
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Fig 6.2 and 6.3: Overview o f HB4a cells as seen under electron microscopy. In each image a single 
cell can be seen. The cells are in the correct orientation with the apical side uppermost in the image. 
The cells are thickest in the centre and narrow down at either end. No gold labelling or cell 
ultrastructure can be seen due to the low level o f  magnification. (Magnification x4000 and x6000 
respectively)
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Fig 6.4 and 6.5: Localisation o f XOR in distinct ‘packets ’ at the apical surface o f the cell. In both 
images the cells appear ‘upside down' with the apical membrane towards the bottom o f the page. The 
gold ‘packets ’ are highlighted in Figure 6.4 by red circles. (Magnification x20,000 and x60,000 
respectively)
Fig 6.6: More bundles o f gold, with the occasional Fig 6.7: Labelling seen within the cell nucleus,
single particle. An unlabelled mitochondrion is The nuclear membrane is indicated by black
indicated by a blue arrow. (Magnification x 100,000) arrows. The nucleus appears grainy with the
nuclear membrane and other cytoplasmic 
membranes appearing as light stripes. 
(Magnification x60,000)
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Fig 6.7 shows localisation of XOR to the nucleus of the cell. There appeared to be a 
greater concentration of nuclear gold labelling in these cells when compared to the 
endothelial cell lines studied, where the nuclear labelling could be more sporadic and 
appeared largely dependent on the cell density. The nuclear membrane can be seen as 
a lighter band running around the outside of the nucleus, which is grainy in 
appearance.
Statistical analysis of the staining (see Appendix) demonstrated high levels of 
labelling in the apical area of the cells, as well as high levels of gold in small 
‘packets’ and the nucleus.
6.3.3 Localisation o f XOR in cells embedded in epoxy resin
As previously stated the advantage of using epoxy resin is better preservation of cell 
ultrastructure than in LR White resin. Thus the use of both methods, gives a more 
accurate picture of localisation than the use of one method alone. In all the images 
referred to in this Section, a purple arrow highlights the gold labelling, as the low 
abundance of labelling makes it less obvious.
Fig 6.8 shows localisation of XOR to a putative vesicle. The two gold particles 
appeared to be almost on the outside of the vesicular membrane. However, the very 
nature of labelling with first a primary antibody and then a secondary gold-conjugated 
antibody means that the gold particle is not in directly the same place as the enzyme 
but rather adjacent to it (the gold particle alone has a diameter of lOnm). Therefore
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Fig 6.8 : Localisation o f XOR to a putative vesicle. 
Two large lysosomes can be seen to the right o f the 
labelling, indicated by a *, with another, 
seemingly empty vesicle in the bottom left hand 
corner o f the image. (Magnification x100,000)
Fig 6.9: Labelling in the Golgi apparatus.
The Golgi lumen appear as white globules 
within the cytoplasm and the crescent shaped 
distribution o f the Golgi body can clearly be seen 
under lower magnification.
(Magnification x75,000)
Fig 6.10: Four gold particles in a vesicle budding Fig 6.11: Localisation ofXOR in a putative
o f the Golgi apparatus. The rough Endoplasmic lysosome or endosome. (Magnification x 60,000)
Reticulum is indicated by a red arrow.
(Magnification x75,000)
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this result clearly shows association of XOR with a vesicular structure and does not 
rule out localisation the enzyme to the luminal side of the vesicular membrane. This 
supports the hypothesis that the ‘packets’ of gold seen in the LR White sections are 
vesicle-associated.
The bulbous appearance of the Golgi apparatus is apparent in Fig 6.9. Under these 
experimental conditions the organelle can be seen quite clearly with localisation of 
XOR to the inside. The Golgi apparatus can again be observed in Fig 6.10. Here four 
gold particles can be seen in a vesicle that appears to have budded from the Golgi 
apparatus, suggesting that the enzyme is being transported from the Golgi apparatus. 
A Golgi stack to the right of the labelling has membrane bound bodies apparently 
budding off, giving the appearance of peas popping out of a pod. Once again, the 
higher quality of ultrastructure achieved by utilising this methodology is apparent. It 
is even possible to see the ribosomes on the rough endoplasmic reticulum (rER) to the 
left of the Golgi.
Fig 6.11 shows localisation of XOR to a large granular membrane-bound body, 
potentially an endosome or lysosome. This observation was rare and was not seen at 
all in the LR White sections, possibly because of destruction of membrane in the 
latter, resulting in the loss of many such structures.
Nuclear labelling was observed in both LR White and in epoxy resins. XOR appeared 
to be membrane bound or lodged in nuclear pores. This can be readily observed in 
Figs 6.12 and 6.13. Although labelling of the nuclear membrane itself was not seen in
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Fig 6.12 and 6.13: Localisation o f  XOR to the nuclear membrane -  in both instances the nuclear 
membrane is indicated by a black arrow. A star indicates the nuclear side o f the membrane. 
(Magnification x75,00 andxlOO,00 respectively)
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the LR White sections for this cell line, this may simply reflect the limited number of 
samples analysed.
6.3.4 Controls
Two staining controls were used (see Appendix) as described for endothelial cells in 
Section 5.3.4. Once again, the controls indicated that the labelling observed was 
neither non-specific nor a result of non-antigenic binding of the primary antibody.
6.4 Localisation bv confocal microscopy
Immunofluorescent localisation of XOR was carried out as described in Section 4.6. 
The results were consistent and reproducible, with all negative controls (labelling in 
the absence of primary antibody) showing very little non-specific staining (see 
Appendix). It was found, as mentioned previously, that fixing with paraformaldehyde 
caused a degree of permeabilisation. Therefore, all pictures and results are from 
permeabilised cells.
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6.4.1 Localisation o f XOR in HB4a mammary epithelial cells
Fig 6.14 shows several stained cells. Punctate perinuclear staining is seen along with 
intense nuclear staining. The nuclear staining seems to be more prevalent in the 
mammary epithelial cells than in the endothelial cells and is less dependent on cell 
density.
Fig 6.15 shows a higher magnification of a single cell. Nuclear staining can be seen, 
with the nucleosomes showing up due to their lack of staining. Both Figs 6.14 and 
6.15 show the larger cytoplasmic ‘vesicular’ staining that was observed with 
endothelial cells in Chapter 5. Fig 6.16 is another close up of a single cell where 
punctate perinuclear staining can be clearly seen, although the cytoplasmic labeling is 
more diffuse than in the previous two images and lacks the larger punctate staining.
6.4.2 Localisation o f XOR in apoptotic cells
Fig 6.17 is an example of normal HB4a cells stained with the monoclonal antibody 
against XOR (conjugated with a red fluorescent tag) and the green fluorescent 
TUNEL reaction, which marks fragmented DNA and is used as a marker for 
apoptosis. There is little TUNEL staining and the only co-localisation between 
TUNEL and the anti-XOR antibody are in areas of cell blebbing. The staining could 
be accounted for by non-specific aggregation of antibodies and stain in the dead cell 
body.
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Fig 6.14: Localisation o f XOR in HB4a cells. The nuclei, indicated by red arrows, appear to have the 
most labelling with a notable absence in the nucleosomes (indicated by black arrows).
Fig 6.15 and 6.16: Localisation o f XOR in a single HB4a cell. In both cases the nuclei are ringed by a 
grey dotted line. The cytoplasm extends beyond the nucleus and is slightly easier to visualise in Fig 
6.16 due to its 'rough ’ appearance.
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Fig 6.18 shows the same staining in HB4a cells driven into apoptosis by 5mM sodium 
butyrate, as described in Section 4.1.9. Here far more green nuclear TUNEL staining 
can be seen, which seems to co-localise with nuclear XOR staining. Where both are 
present it shows up on the image as a yellow colour. However, the XOR staining in 
general was much weaker and more diffuse in these cells, suggesting that either 
apoptosis had reduced the enzyme level or that the XOR labelling was only partially 
successful.
6.4.3 Localisation o f XOR and actin
Staining was performed on HB4a cells to label XOR, utilizing the monoclonal 
antibody conjugated to a green fluorescent tag, and actin, utilising the phalloidin toxin 
conjugated to a red fluorescent tag, as described in Section 4.62.
Figs 6.19-6.21 show punctate nuclear and perinuclear staining for XOR in all the 
cells. The bundles of actin filaments show up clearly, particularly in the top left hand 
comer of Fig 6.21. There is no co-localisation between actin and XOR.
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Fig 6.17: Localisation o f XOR (red) and TUNEL (green) in apoptotic HB4a cells before treatment with 
sodium butyrate. The usual punctate staining for XOR can be observed, and the slight green colour o f 
the nucleus in centre view may indicate that it is apoptotic. However, the yellow 'blob ’ (where yellow 
indicates co-localisation o f  XOR and TUNEL), indicated by a blue arrow, is most likely aggregation.
Fig 6.18: Localisation o f XOR (red) and TUNEL (green) in apoptotic HB4a cells after treatment with 
sodium butyrate. The nuclei, marked by black arrows, appear yellow where the XOR label is co- 
localising with TUNEL. Very little o f the normal punctate labelling can be seen and the XOR labelling 
is weaker than in other samples.
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Fig 6.19, 6.20 and 6.21: Localisation o f XOR (green) and actin (red) in HB4a cells. XOR is seen as 
green, largely nuclear, punctate staining. Some cytoplasmic staining can be seen in Fig 6.20. The 
bundles o f  actin, indicated by a white arrow, are clearly labelled in Fig 6.21, although the lack o f 
yellow colouration in any o f the images indicates a lack o f co-localisation.
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6.5 Discussion
Levels of XOR activity, detected by the pterin assay (Beckman et al, 1989), as 
described in Section 4.3, were at the limit of detection for the HB4a cell line. 
Attempts to compensate for this by increasing the sample concentration resulted in an 
increase in light scattering and difficulty in calibrating the assay. Although it can be 
seen that pterin dependent XOR activity increases with cell numbers (Fig 6.1), it is 
difficult to draw any further conclusions.
The activity of XOR in these cells seemed to be dependent on when the cell medium 
was changed. Pterin-dependent XOR activity could be detected 24h after the medium 
was changed, but after 48h the activity dropped to either low or undetectable levels. 
This phenomenon was more pronounced at the end of the growth curve, and reflects 
the limited nutrients and acidification of the media after 48h, but it is odd that it was 
not observed in the endothelial cells. Taken at face value, the observation suggests 
medium-dependent switching on and off* of XOR activity. While intriguing, this idea 
is clearly highly speculative and would require considerable further study for its 
confirmation.
NO production was not detected from HB4a cells, probably because of the 
intrinsically low XOR activity. Immortalisation of the HB4a cell line may have 
resulted in a down-regulation of the enzyme, as observed in cancerous cells (Ikegami 
1986). Detergents were incorporated into the assay to ensure access of the substrates 
to any cytosolic enzyme, all to no avail. It was impossible to predict what NO 
scavengers were present in the assay due to the use of whole cells. For example, the
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normal purine catabolism of XOR produces urate, a known NO scavenger (Doel, 
2001).
Localisation of XOR by means of electron microscopy showed discrete ‘packets’ of 
cytosolic gold labelling (see Figs 6.4, 6.5), often seen to be concentrated in the apical 
part of the cell. In both epoxy resin and LR White embedded samples, the pattern of 
staining and surrounding ultrastructure indicates that the enzyme was localised in 
vesicles. There also appeared to be staining within the Golgi apparatus (see Figs 6.9, 
6.10), although this was not as well defined as in the other cell lines. Overall these 
results suggest that the enzyme is being packaged into vesicles for transport, possibly 
to the cell surface.
It is reasonable to speculate that this may be the same pathway that results in the 
binding of XOR, via glycosaminglycans, to the surface of endothelial cells (Radi et al, 
1997). XOR is also found in serum (Benboubetra et al, 1996) and bile (H Martin, 
unpublished) and therefore must either be secreted or released from damaged cells.
The apparent localisation of XOR to the lysosome/endosome (see Fig 6.11) supports 
previous observations (Holt, 2000). If the body observed is indeed an endosome, this 
suggests that the enzyme is endocytosed from the cell surface (Radi et al, 1997), and 
that the cells are capable of recycling XOR.
Localisation of XOR via confocal microscopy demonstrated both nuclear and 
punctate staining (see Figs 6.14 - 6.16), as observed in the endothelial cells. In HB4a 
cells, there was no labelling of larger endosome-like structures visible on the
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transmitted light image. This could be explained by the fact that HB4a cells are flatter 
than the endothelial cells, resulting in less clear light transmitted images and thus 
making cell ultrastructure more difficult to visualise. Alternatively, the lack of 
endo some-like structures may have been due to the fact that the correct conditions 
were not created for the formation of these structures, or it may be a reflection of the 
function of the enzyme within the cell type. If XOR were acting as a paracrine 
messenger from endothelial cells, then levels of enzyme would only need to be 
maintained on the surface of the cell. Once the necessary levels have been obtained 
then any further enzyme produced may well be stored. In mammary epithelial cells it 
is more likely that the enzyme is being constantly secreted and there would be no need 
for storage.
The nuclear staining was distinctly different to that seen in endothelial cells (see 
Chapter 5) an observation supported by the localisation seen via electron microscopy. 
Nearly all cells visualised under the confocal microscope showed intense staining for 
XOR within the nucleus, regardless of the cell density. While intense nuclear staining 
was observed in endothelial cells, it was largely restricted to post-confluent cells, with 
any nuclear staining in sub-confluent cells appearing weaker in comparison. The 
consistent nuclear labelling within HB4a mammary epithelial cells may reflect a role 
for the ROS produced by the enzyme in apoptosis or other signalling pathways 
resulting in the activation of transcription factors (reviewed by Hancock et al, 2001).
To investigate further the potential nuclear role of XOR further, apoptotic cells were 
stained for both XOR and TUNEL. TUNEL staining labels fragmented DNA and is 
an early marker of apoptosis. The results were disappointing. Cells driven into
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apoptosis by sodium butyrate did not demonstrate elevated levels of labelling for 
XOR, and co-localisation with TUNEL was inconclusive (see Figs 6.17 and 6.18). If 
the enzyme were contributing to the apoptotoic pathway via the production of ROS, it 
would appear that it does so without any apparent change in XOR’s cellular 
localisation.
In an attempt to further investigate the punctate staining seen in HB4a cells, samples 
were stained for XOR and actin (see Figs 6.19-6.21). Actin staining was accomplished 
by using a phallotoxin, which irreversibly binds to actin filaments. It was hoped that, 
if the punctate staining represented vesicular transport, that the secretion pathway was 
being directed by the cell cytoskeleton and co-localisation would be seen. However, 
in these samples, little punctate cytosolic staining was seen, with the majority of the 
labelling being in the nucleus. What cytosolic staining there was showed no co­
localisation with the actin filaments. If the punctate staining in these cells does 
represent a vesicular secretion pathway, it does not appear to be regulated by the 
cytoskeleton.
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7 A c t i v i t y  a n d  L o c a l i s a t i o n  o f  XOR in  G u t  E p i t h e l i a l  C e l l s
The interaction of immune cells with the gut epithelium plays an important role in 
host defence, acting to eliminate pathogens and antigens from the lumen of the 
gastrointestinal tract. One main function of the intestinal epithelium is to act as a 
barrier to limit uptake of antigenic material and microbes from the lumen. The 
presence of XOR activity in the small intestine (Kooij et ol, 1992) suggests a role for 
the enzyme in the digestive tract, and it was decided to investigate the localisation and 
activity of XOR in cultured gut epithelial cells.
The permanent human colon carcinoma cell line, Caco-2, was used as a model for gut 
epithelial cells. These cells are of interest because they show differentiation patterns 
characteristic of mature enterocytes. Post-confluent cells are covered by functionally- 
differentiated brush border microvilli, and the cells are structurally and functionally 
polarised (Rothen-Rutishauser et al, 2000).
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7.1 Growth curve and pterin activity
Cells were seeded at the same density in multiple flasks and, as described in Section 
4.1, harvested at set intervals for fluorimetric assay. Assays were performed on 
samples from three flasks at the same stage in growth, and all assays were done in 
duplicate. The pterin assay was performed as described in Section 4.3 with 
appropriate controls.
Despite numerous attempts, pterin-dependent XOR activity was not detected in Caco- 
2 cells. Cell numbers were increased, preparations of whole cells, disrupted cells and 
cell fractions were all used and the assay conditions were varied, all to no avail. As 
noted with the endothelial cells (see Chapter 5), increasing the sample size created 
more turbidity and light scattering, making internal calibrations impossible.
7.2 Nitric oxide activity
NO levels were measured as described in Section 4.5. Results were, once again, 
unpredictable and difficult to reproduce. Varying the electron-donating substrates 
(xanthine, hypoxanthine and NADH) along with various combinations of inorganic 
and organic nitrates and nitrites did not lead to predictable results. Fig 7.1 shows data 
obtained with Caco-2 cells in the presence of lOOpM xanthine and lOOmM sodium 
nitrite and at constant pH (7.2), maintained by a pH stat.
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As for the other cell lines discussed in previous Chapters, the irreproducibility of data 
precluded meaningful use of specific XOR inhibitors. Accordingly the only evidence 
to support the catalytic involvement of XOR in NO production is the requirement for 
XOR substrates within the assay.
NO Production from Caco-2 cells
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Fig 7.1: NO production from the gut epithelial cell line Caco-2 in the presence o f 100pM  xanthine and 
lOOmM sodium nitrite. The substrates were allowed to equilibrate in the reaction chamber with the 
buffer. The reaction was started at about 60 secs (where the peak can be seen) by the addition o f o f cell 
suspension (I ml). The reaction chamber was kept anoxic by the constant flow o f oxygen-free nitrogen 
through the vessel and the cells were maintained in suspension by constant stirring.
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7.3 Localisation by electron microscopy
Electron microscopy was carried out as detailed in Section 4.7. Cells were embedded 
in either epoxy or LR White resin and samples were preserved either chemically or by 
slam freezing. Only monolayers of Caco-2 cells showing characteristics of dome 
formation were used in this Section.
7.3,1 Cell morphology
Dome formation, a characteristic of maturation in Caco-2 cells, can be seen in striking 
detail when viewed under an electron microscope. Fig 7.2 shows an example of the 
way that these cells form multiple layers. Individual cells are best identified by means 
of their nuclei. A cartoon below the electron micrograph indicates how cells pile up 
on top of the monolayer to form a dome. Many of the samples showed intense 
vesicular activity at the apical cell surface. This was often accompanied by an 
increased number of Golgi within the cell and microvilli on the cell surface. However, 
domes proved to be difficult to find whilst sectioning.
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Fig 7.2 : Caco-2 cells are seen piling up to form a dome in the image above. Four cells can be seen in this 
image, with the nuclei o f cells 1 and 2, indicated by red arrows, appearing more grainy and bordered by dark 
nuclear membrane. The three dark stripes are creases in the resin where the sections were cut. No gold can be 
seen at this magnification (x4000). Below is a cartoon o f a dome with a boxed area showing how the above 
cells may have formed part o f the dome structure.
Insert
Cells
It is thought that the centre o f  the 
dome is filled
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7.3.2 Localisation o f XOR in cells embedded in LR White resin
As mentioned in previous Chapters, the sample preservation and resin hardening 
methods used with LR White resin can often result in improved labelling, but this is at 
the expense of ultrastructural definition in the cell. Samples preserved in this manner 
showed optimum levels of staining and all the images in this Section were derived 
from slam-frozen samples. A primary antibody concentration of 1/100 for 1D9/D1 
gave the best staining with minimal background.
XOR is apparently localised to bundles or packets within the cell, as seen in Figs 7.3- 
7.6. This highly reproducible pattern of staining may well indicate localisation to 
vesicles, which in several cases are in abundance close to the cell surface.
Figs 1.1-1.9 show localisation of XOR to membrane structures within the cell. 
Although the ultrastructural detail in these samples is poor, the characteristics of the 
membrane structure suggest either Golgi apparatus or endoplasmic reticulum, 
organelles that are responsible for the secretion of proteins.
Figs 7.10 and 7.11 show the levels of staining seen in cells largely lacking microvilli. 
When compared to Figs 7.12 and 7.13 it can clearly be seen that the levels of XOR in 
mature cells (those with a brush border) are higher than those in immature cells. 
Whilst the number of clusters of gold may not differ greatly, the amount of labelling 
within each cluster is clearly elevated in mature Caco-2 cells.
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tears si
Fig 7.5 : XOR in putative vesicles at the cell surface. Fig 7.6: Close up o f on o f the ‘packets ’ o f  gold 
(Magnification x60,000) at the cell surface. Again, the gold is clustered in
a circular pattern 
(Magnification xl20,000)
Fig7.3: Labelling o f  XOR in two discrete ‘packets ’ 
near the cell surface. The cluster closest to the 
arrow app pherical. (Magnification x 100,000)
Fig 7.4: Overview o f the spread o f  gold clusters. 
Clusters are highlighted with red circles. 
(Magnification x50,000)
In all the images the cell surface can be identified by the blue arrow. In many o f the images, microvilli, 
or sections o f microvilli (seen as spherical dark patches where they have been sliced in cross-section) 
are visible beyond the cell surface.
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Fig 7.7: Localisation o f XOR in 'packets' adjacent to Fig 7.8: Localisation o f XOR to another 
a membrane bound structure. (Magnification x75,000) membrane bound organelle.
(Magnification x75,000)
In all the images the membrane is indicated by 
the red arrow and the cell surface by a blue 
arrow. The membrane appears as a light stripe 
against the grey o f the cytoplasm and a white 
dashed circle rings the extent o f the membrane. 
In Figs 7.7 and 7.9, the bulbous nature o f the 
membrane bound organelle is reminiscent o f 
the Golgi apparatus.
Fig 7.9: Localisation o f XOR to the Golgi or endoplasmic 
reticulum membrane. (Magnification x120,000)
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Fig 7.10 and 7.11: Relatively low levels o f staining seen in immature cells bearing few  microvilli. The 
cell surface is shown by the blue arrow and gold labelling by red circles. (Magnification x60,000 and 
x50,00 respectively)
Fig 7.12 and 7.13: High levels o f  staining seen in mature cells bearing microvilli. The cell surface is 
shown by the blue arrow, microvilli by the green arrow and gold labelling by red circles. On average, 
there is a greater amount ofgold labelling in each o f the highlighted areas than in the previous images. 
(Magnification x60,000 and x50,00 respectively)
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Statistical analysis of the labelling (see Appendix) showed association of the enzyme 
with small vesicle like packets and the Golgi apparatus. This strongly suggests 
involvement of XOR in cellular regulatory and secretion pathways.
7.3.3 Localisation o f XOR in cells embedded in epoxy resin
Despite repeated efforts Caco-2 cells were not successfully embedded in epoxy resin. 
Samples viewed under both light and electron microscopy showed cells with severe 
plasma membrane damage and cytosolic leakage. The reason for this is unclear, but it 
may be that the cells were particularly sensitive to part of the fixing or embedding 
process.
7.3.4 Controls
Controls (see Section 5.3.4) once again showed that labelling with the primary 
1D9/D1 monoclonal anti-XOR antibody was specific. Results for all controls can be 
found in the Appendix.
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7.4 Localisation bv confocal microscopy
Staining was carried out as described in Section 4.6. As with the other cell lines 
studied, fixation caused permeablisation of the cell membrane Therefore all the results 
in this section are from permeablised cells.
7.4.1 Localisation o f XOR in immature and mature Caco-2 cells
The mature characteristics of Caco-2 gut epithelial cells are greatly enhanced when 
the cells are grown on an insert (allowing media to both sides of the cell layer) 
compared to when grown on coverslips (only allowing media to the apical side of the 
cell layer). Thus staining for XOR was carried out on cells grown on both inserts and 
coverslips.
Fig 7.14 shows the typical punctate staining seen in immature Caco-2 cells. In this 
case the cells were grown on cover slips. Once again the punctate staining seen in the 
other cell lines can be observed. The edge of the clump of cells appears devoid of any 
labelling. This is undoubtedly misleading and the reason why no fluorescence is seen 
is that the edge of the clump of cells is below the plane of focus and does not reflect 
an absence of XOR.
Fig 7.15 also shows localisation of XOR in Caco-2 cells, but this time the cells have 
been grown on inserts. The pattern of staining was similar to that seen before, 
although there appear to be larger areas of punctate staining. It is hard to tell whether
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Fig 7.14: Localisation o f XOR in Caco-2 
monolayer. A clump o f cells can be seen in 
in this image. The cell boundary is shown by 
blue arrows.
Fig 7.15: Localisation o f XOR in Caco-2 in a 
confluent monolayer. Cell nuclei appear free o f  
staining (indicated by a white arrow) and the 
cytosol is filled with both large and small punctate 
staining.
Fig 7.16 and 7.17: Localisation o f XOR in Caco-2 domes. In the first image two small, newly formed 
domes can be seen. The upper dome consists o f one cell and the lower dome o f two and in both cases 
the cells appear ringed with staining fo r XOR. In the second image the dome has spread so much that it 
appears as a sheet over the monolayer and comprises o f in the region o f 20 cells. In both images white 
arrows indicate the nuclei o f  the cells in the monolayer benath the dome. No staining at all can be seen 
in the monolayer.
or not this is membrane associated, as it was difficult to resolve a light transmitted 
image of cells grown on inserts. One instantly striking feature is the complete absence 
of staining in the cell nuclei.
Figs 7,16 and 7.17 show typical patterns of localisation in mature cells grown on 
cover slips. The cells ringed with red labelling for XOR are growing on top of the cell 
monolayer and form part of a ‘dome’ (see Fig 7.2). Dome formation is one of the 
characteristics of Caco-2 maturation. The cells forming the domes always show more 
intense staining than those forming the monolayer beneath, and it would seem from 
the pattern of staining that the enzyme was located at the apical periphery of these 
cells. It is noteworthy that the labelling for XOR seen in Caco-2 domes grown on 
coverslips is diffiise and shoes none of he punctate staining seen in all other samples. 
The complete lack of labelling observed in the monolayer of these images is 
artifactual. No fluorescence can be detected because the sensitivity of the equipment 
needed to be reduced to prevent the intense staining within the dome turning into a 
blur. Whilst this results in false negative results for the monolayer in many of the 
images, it does give an indication of the intensity of the staining in the domes.
Fig 7.18 shows a progression of images taken through a Caco-2 dome formed from a 
monolayer of cells grown on coverslips. The top left hand image is of the basal layer 
of the cells (including the unstained cell monolayer beneath) and each subsequent 
image (viewing left to right, top to bottom) is slightly further up (distance is indicated 
on each picture) in the domes until finally the apical side of the cells is seen. Once 
again these cells were grown on cover slips. This ‘z sectioning’, demonstrates further
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Fig 7.18: Localisation o f XOR in a Caco-2 dome, showing serial slices from basal to apical side o f a 
single dome. As the confocal microscope scans from the case o f the cells up, it can be seen that the 
staining seen to ‘ring’ the cells in the earlier images is in fact diffuse staining covering the entire 
periphery o f the cells in the dome. Four cells can clearly be seen in this image and are indicated by 
white arrows in one o f the middle sections. As the view moves upwards, the top o f each o f the cells can 
be seen by the red 'cap ’ o f fluorescent labeling (indicate by a blue arrow).
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that the staining for XOR is most intense at the outer edge of the cells forming the 
dome.
Fig 7.19 shows the localisation of XOR in a Caco-2 dome formed from a monolayer 
of cells grown on an insert. A network of lines of XOR can be seen crossing the 
dome, along with more punctate staining for the enzyme. The ‘haimet’-like pattern of 
staining seems to be localised to the boundaries between cells making up the dome. 
Fig 7.21 shows the 3D image of the dome being turned through 360°. Viewed from 
the side it can be seen that the dome actually protrudes from the monolayer, and the 
greater intensity of staining in the dome, compared to the monolayer becomes evident. 
This staining is markedly different from that of cells grown on coverslips, where the 
staining in the domes was more diffuse. However, Fig 7.20 shows z-sectioning 
through the same dome as that pictured in Figs 7.19 and 7.21 (this time travelling 
from the apical side of the dome to the basal side). This demonstrates that, whilst the 
pattern of staining was quite different from that seen in Caco-2 domes grown on 
coverslips, the staining was still at its most intense at the outer edge of the dome.
7.4.2 Localisation o f XOR in barrier- positive and barrier-negative Caco-2 cells
Caco-2 cells grown on cell culture inserts were provided, ready fixed, by Dr Roger 
Hurst of the University of the West of England, Bristol. These cells are grown in the 
same manner as the cells described in Section 5.4.2, with the intention of modelling 
the blood-brain barrier (Roger Hurst, verbal communication). ‘Barrier-positive’ is 
shorthand for co-cultures that have developed high transcellular resistance, tight
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Fig 7.19: Localisation o f XOR in a Caco-2 
dome. Many cells make up this single dome 
and some o f the cell boundaries can be seen 
highlighted by the hairnet like fluorescent 
staining for XOR.
Fig 7.20: Localisation o f  XOR in the same dome.
The image shows serial z-sections o f a single dome 
starting at the top o f the dome and passing on down to 
the monolayer the some is formed upon. The brightest 
staining is around the periphery o f the dome.
Fig 7.21: Localisation o f XOR in the same caco-2 dome: 3D image turned through 360°. This image is 
built up by layering the serial z-sections, seen in previous images, on top o f each other to generate a 
3D image. This image can then be rotated so that the localisation o f  XOR can be seen from above the 
dome, from the side and below. The side on image is indicated by a * The intensity o f  the staining in 
the dome when compared to the monolayer is apparent, as is the height o f the dome.
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junctional complexes and restricted permeability that can be modulated by osmotic 
shock (Garberg 1998). The aim of this Section was to determine if cells displaying 
‘barrier-positive’ characteristics showed different patterns of localisation of XOR 
compared to normal cells. Localisation of XOR was carried out as described in 
Section 4.6.
Fig 7.22 shows localization for XOR (green) and actin (red) on barrier-positive Caco- 
2 cells. The network of staining seen on the domes in Fig 7.19 is repeated but seems 
to be more pronounced. There is no co-localisation with actin, showing that the XOR 
staining was not linked to the actin infrastructure of the cells.
Fig 7.23 shows serial z-sections, going from the basal through to the apical side (see 
legend), of a dome formed on a monolayer of barrier positive cells. Again, XOR is 
shown in green and actin in red. This image demonstrates that the centre of the dome 
lacks any comparable labelling for XOR, showing itself as a circular area devoid of 
fluorescence (almost the reverse of the ‘yolk of the egg’ anology used previously to 
describe nuclear labelling). It seems strange that there is a complete lack of nuclear 
staining within these cells.
Figs 7.24 and 7.25 show the pattern of XOR localisation seen in barrier negative cells. 
The ‘hairnet’ like network of staining was much more apparent in these samples, 
seeming to mark out the boundaries between individual cells within the dome. Again, 
XOR is shown in green and actin is shown in red. In these cases, low levels of 
punctate XOR staining can be seen in the monolayer. The lack of yellow (seen when
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Fig 7.22: Localisation o f XOR and actin in 
barrier positive Caco-2 domes (XOR -  green, 
actin -  red). Three ball like domes can be seen 
in this image. No labelling can be seen in the 
monolayer beneath.
Fig 7.23: Localisation o f  
XOR and actin in barrier 
positive caco-2 domes, serial 
z-sections (XOR -  green, 
actin -  red). Once again the 
sections start at the top o f 
the cell and move down to 
the monlayer beneath. There 
is a spherical area within the 
dome that is devoid o f all 
staining, indicating the lack 
o f XOR in the centre o f the 
dome. The cells within the 
domes are smaller than those 
comprising the monolayer 
and there are many cells in 
this single dome.
Fig 7.24 and 7.25: Localisation o f XOR in caco-2 barrier negative domes (XOR -  green, actin -  red). 
The network o f staining in these images can clearly be seen to outline the cells within the dome, 
although there is no co-localisation with actin, apparent by the lack o f  yellow labeling (yellow labeling 
is generated when both red and green labeling co-incide). Punctate staining can clearly be seen in the 
monolayer.
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the two fluorescent tags co-inside) shows that there was no co-localisation between 
the XOR and actin.
7.4.3 Localisation o f XOR in apoptotic Caco-2 cells
Enterocytes are dynamic cells that, in vivo, are constantly undergoing a process of 
maturation and cell death. It has been previously hypothesised that the free radicals 
produced by XOR may play a part in the signalling cascade, which eventually results 
in apoptosis and cell death (Page, 1999). Fig 7.26 shows Caco-2 cells that have been 
stained for XOR (red) and TUNEL (green), which labels fragmented DNA and is an 
early indicator of apoptosis. Whereas a degree of co-localisation can be seen, as 
demonstrated by the yellow colour produced when the two fluorescent tags coincide, 
this result was not consistent.
7.4.4 Localisation o f XOR. zonular occludens and catenin p
In the next Section, XOR is shown to be localised alongside various proteins that form 
complexes in the junctions between cells. Fig 7.27 gives an overview of a cell 
junction and is useful when interpreting the data. Fig 7.28 shows localisation of tight 
junctions within a monolayer of Caco-2 cells. This was achieved using the primary 
monoclonal antibody ZO-1, which is directed against zonula occludens, a protein 
within the tight junction complex (see Fig 7.27). The staining appears as crazy paving 
and the boundaries between cells can be clearly seen.
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Fig 7.26: Localisation o f XOR (red) and 
TUNEL (green) in Caco-2 cell monolayer. 
Yellow indicates co-localisation o f TUNEL 
and XOR although the shape o f the cell and its 
Distance from the monolayer indicate that the 
Staining is probably due to aggregation within 
a dead cell.
Fig 7.28: Localisation o f zonular occludens in 
a Caco-2 monolayer. The cell boundaries where this 
tight junction protein is found are clearly marked by 
the green staining.
Fig 7.29: Localisation o f zonular occludens in a caco-2 dome: serial z-slices from basal to apical side 
o f the dome. Once again, the cell boundaries between the cells in the monolayer can clearly be seen in 
the first few images. Then, as the perspective shifts up into the dome, the boundaries o f the cells within 
the dome can be seen.
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Fig 7.27: The localisation o f various junctional complexes formed between epithelial cells. The actual 
size o f the gap between the cells can clearly be seen in b, where the gap can be seen to widen towards 
the basal side o f the cells (taken from Tsukita et al, 2001)
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Fig 7.29 shows the localisation of tight junctions within a dome formed by post­
confluent mature Caco-2 cells. The series of images are z-sections progressing from 
the basal side of the dome up to the apical layer. Again, the tight junctions appear as 
crazy paving, outlining each individual cell and revealing the structure of the dome 
more clearly.
Fig 7.30 demonstrates the staining seen with a polyclonal antibody against catenin p. 
This is a protein that is found lower down in the junction, in the adherens junction 
(see Fig 7.27). The gap between the neighbouring cells is wider in this area; hence the 
less well defined staining. However, the boundaries between the cells can just be seen 
in the serial images.
XOR staining is again seen in Fig 7.31 (red fluorescence) alongside that for catenin p 
(green fluorescence) in a dome of Caco-2 cells. This image is of the very top of a 
dome. Once more the XOR appears in a network, as does the adherens junction 
protein. When the two images are overlaid, in Fig 7.32, co-localisation is evident by 
the yellow colour. This indicates that XOR is indeed localised to the junctions 
between dome-forming cells.
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Fig 7.30: Two sections through the same area o f a Caco-2 dome stained with anti-catenin f3. This 
protein localises further down in the cell boundary than ZO-l and it is less easy to see the cell 
boundaries.
Fig 7.31: Two pictures o f the same area showing XOR (red) and catenin (3 (green). This image is taken 
from the very top o f a dome, where the cell boundaries o f the uppermost cells within the dome can be 
seen.
Fig 7.32: Overlay o f images in 7.30, yellow signifies 
co-localisation o f XOR and catenin (3, indicating that 




XOR activity in cells is typically measured by using the pterin assay (Beckman et al, 
1989), as described in Section 4.3. This is a sensitive fluorimetric assay able to detect 
low levels of XOR activity (down to as low as 0.5pmole/min/mg isoxanthopterin 
production). However, no pterin-dependent XOR activity was detected in Caco-2 
cells, despite several variations in protocol. Such changes included the use of whole 
cells and cell fractions, detachment of cells by trypsinisation and mechanical scraping. 
Detergents were also used in attempts to allow better access of the substrates to the 
enzyme. Any XOR activity within these cells was clearly below the lower limit of 
detection of the pterin assay.
Confocal microscopy, electron microscopy and Western blotting (results not shown 
due to difficulties encountered scanning the blots) all showed that XOR protein was 
present in this cell line, which leaves the question of why no activity could be 
detected. One possible explanation is that XOR activity has been shown to be down- 
regulated (Weber et al, 1978) or non-existent (Moriwaki et al, 1996) in cancerous 
cells, and the Caco-2 cell line is derived from a human colon carcinoma. Another 
potential explanation is that the preparation of the cells for assay resulted in the loss of 
the enzyme, whilst preparation of the cells for microscopy did not. Both of these 
possibilities are explored in Chapter 8.
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It is possible that, for all the cells considered in this study, the low levels of XOR 
activity reflect the activity of the enzyme in most human tissues (Harrison, 1997). 
Moderately high levels of XOR activity have only been reported histochemically in 
the liver and small intestine (Kooij et al, 1992), and it is possible that other human 
tissues contain largely inactive XOR protein (Harrison, 1997). However, low xanthine 
oxidase activity does not necessarily not preclude other (eg NADH oxidase) 
functions.
Nitric oxide production from Caco-2 cells proved to be unpredictable, despite many 
attempts at optimizing the assay by varying conditions, substrates, buffer and even the 
reaction vessel used. Positive results were obtained occasionally, although the source 
of detected NO was uncertain. Non-enzymic production of NO by acidification of 
nitrites was ruled out by the use of a pH stat, as described in Chapter 5, and NO 
production by NOS is unlikely due to the feet the the assay was carried out under 
anoxic conditions. Nevertheless, the only evidence supporting XOR as the source of 
NO is the requirement for XOR substrates in the assay.
Immunolocalisation of XOR via electron microscopy demonstrated that the enzyme 
was associated with the microvilli, vesicular-like structures and either the Golgi 
apparatus or endoplasmic reticulum. The labelling suggests some kind of active 
transport from the secretory apparatus into secretory vesicles and then, potentially, to 
the external surface of the cell. The staining in the microvilli in these cultured cells is 
consistent with the localisation of XOR activity, via electron microscopy, to the 
microvillli of epithelial cells in intestinal brush border (Van den Munckhof et al, 
1995). What is interesting to note is that, in the present study, the level of enzyme
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seemed higher in cells with microvilli compared to those without (see Figs 7.10-7.13), 
suggesting that mature cells express more XOR.
The localisation pattern of XOR, as determined by electron microscopy, was similar 
to that seen in the endothelial and mammary epithelial cells (see Chapters 5 and 6). 
However, localisation of the enzyme as determined by confocal microscopy showed 
several distinct variations, particularly in mature cells.
Immature, sub-confluent Caco-2 cells showed punctate cytoplasmic XOR labelling 
(see Figs 7.14, 7.15, 7.24, 7.25). The localisation of XOR was not dependent on the 
substrate upon which the cells were grown and labelling frequently appeared to be 
more intense at the leading edge of ‘clumps’ of cells (see Fig 7.14). The cells at the 
very periphery of the clump in Fig 7.14 appear unstained, but this is simply because 
the cells at the very edge are below the focal plane of the microscope. Epithelial cells 
tend to grow in this clump formation and, unlike endothelial cells, do not put out 
processes. It is, accordingly, the leading edge of the clump that is involved in 
signalling to other cells in order to form a monolayer. Therefore this observation 
could indicate a cell-to-cell signalling role, as suggested for endothelial cells in 
Chapter 5. Whilst this pattern of localisation of XOR is similar to that seen in the 
other cell types studied, one distinct difference is the complete lack of nuclear 
labelling, even in cells that have reached confluence but not matured (Fig 7.15).
The clearly defined punctate labelling of XOR in Caco-2 cell monolayers supports the 
evidence, derived from the localisation of XOR by electron microscopy, of vesicular 
association of the enzyme. However, this is inconsistent with the findings of Jarasch
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et al (1981) who found that XOR was cytosolic but did not appear to be localised to 
vesicles or cell organelles. The reproducibility of this observation throughout Chapter 
5, 6 and 7 suggests that it is real. One explanation for the inconsistency of these 
findings with those of Jarasch et al (1981) could be that this study utilised a highly 
specific monoclonal anti-XOR antibody, whereas the majority of work published to 
date relies on polyclonal antibodies.
Localisation of XOR in dome-forming Caco-2 cells was markedly different to that 
observed in the other cells studied (see Chapters 5 and 6). Dome formation is a 
characteristic of mature Caco-2 cells (Rothen-Rutishauser et al, 2000) and is 
accompanied by enterocyte-like features such as cell polarisation and brush border 
microvilli. The staining for XOR within Caco-2 domes was very intense (Figs 7.16- 
7.25) suggesting high levels of the enzyme. Many of the images were so bright that 
sensitivity of the image collecting software had to be turned down to enable 
interpretation of the image, which resulted in the apparent loss of weaker staining in 
the monolayer beneath (Fig 7.16, 7.17).
The pattern of localisation of XOR associated with domes varied depending on the 
substrate upon which the cells were grown. Single cell and multi-cell domes grown on 
coverslips showed intense diffuse peripheral staining circling the cells forming domes 
(Figs 7.16, 7.17). When serial images were taken through the dome (Fig 7.18) it 
appeared that the staining was localised to the periphery of the cells within the dome. 
It was impossible to conclude if this staining was on the outer or inner surface of the 
plasma membrane, or merely localised to the cytosol in the vicinity of the plasma 
membrane, but the serial sections clearly show that the inside of the cells forming the
117
domes have little (bearing in mind the reduced sensitivity of the image collection 
software) to no XOR present.
Cell inserts allow access of the media to both sides of the cells, thus creating an 
environment closer to that found in vivo and promoting maturation of the cells. Caco- 
2 cells grown in this manner readily form mutli cellular domes in which XOR is 
localised in a ‘hairnet’ pattern at the periphery of individual dome-forming cells (Figs 
7.19-7.21), along with more punctate staining, in contrast to the diffuse staining seen 
previously. Association of XOR with the cytoskeleton was ruled out by a lack of co­
localisation with actin (Figs 7.24, 7.25). It was suggested that the ‘hairnet’ pattern of 
XOR localisation could correspond to the cell boundaries of the cells forming the 
domes (R Hurst, verbal communication) and this was investigated further by 
localisation within the domes of the tight junction complex protein, ZO-1.
Localisation of ZO-1 within Caco-2 domes did indeed show a similar pattern to that 
of XOR (Fig 7.29). The boundaries between the cells in both the dome and the 
monolayer beneath can clearly be seen. The localisation of tight junctions within the 
dome is strikingly similar to the localisation of XOR within domes (Fig 7.24). 
However, the observation that the localisation was similar does not provide enough 
evidence to conclude that XOR is localised to the junctions between cells.
In an attempt to determine the precise localisation of XOR within dome-forming 
Caco-2 cells, XOR was co-localised with catenin p (see Fig 7.32). Catenin p is a 
protein found lower down in the adherens junction (see Fig 7.27). The similar pattern 
of staining and the co-localisation is evident, indicating that the enzyme is localised to 
the area between cells. In this case the staining for XOR was slightly narrower than
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that for catenin p, and observation that would be explained if the enzyme was located 
between the zonnular occludens (also known as the tight junction complex) and the 
top of the adherens junction, as the cleft between cells widens between these points.
The junctional localisation of XOR, along with the punctate staining observed earlier, 
may well indicate a transport system to the junctions between the cells forming the 
domes. The enzyme could be anchored in these clefts by association with 
glycosaminoglycans (Radi et al, 1997) or it may merely be secreted into the junction. 
However, there is some disparity between the localisation of XOR in dome-forming 
cells grown on inserts compared to those grown on coverslips. A potential explanation 
for this is that, whilst dome-forming cells grown on coverslips show more of the 
mature characteristics than those cells that form the monolayer beneath, they do not 
mature to the extent of dome-forming cells grown on inserts. It is possible that these 
cells are mature enough to initiate general transport of XOR to the surface of dome- 
forming cell, but that the barrier formed by the cell junctions is not sufficient to direct 
localisation of XOR to the cell junction. Hence cells grown upon coverslips show 
diffuse staining for XOR at the periphery of dome-forming cells and the more mature 
dome-forming cells grown on inserts show the ‘hairnet-like’ pattern of localisation of 
XOR that appears to correlate with the dome-forming cell junctions.
If anything, inducing barrier formation in Caco-2 cells made the network localisation 
less apparent. This phenomenon was only observed in one sample of cells and may be 
an artefact or may represent the lessened need for protection against microbial 
infection when a tighter barrier is present. Given that the pattern of localisation is
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more apparent in mature than immature cells, it is likely that the former conclusion is 
the correct one.
The localisation of XOR in apoptotic cells revealed very little about the enzyme’s 
function. Localisation did not seem to alter in apoptotic cells, nor did it become more 
intense. Pterin-dependent XOR assays were performed on Caco-2 cells driven into 
apoptosis by sodium butyrate, but once again no activity could be detected. XOR may 
play a role in apoptosis, but if it does, it is not revealed by the localisation of the 
enzyme.
Rouquette et al (1998) demonstrated surface staining of XOR with a polyclonal 
antibody raised against the enzyme, although only endothelial and mammary 
epithelial cells were investigated. One of the difficulties in obtaining surface staining 
in the present study was that the paraformaldehyde permeabilised the cells, allowing 
the primary antibody access beyond the cell surface. An attempt was made to 
circumvent this problem by performing live cell staining, hence avoiding the need to 
fix the cells. This proved inconclusive. Live cell staining is a relatively new technique 
and it was hard to tell if the enzyme was not present on the surface or if the 
experimental protocol was at fault. The methodology would need to be optimised and 
positive controls incorporated to obtain a conclusive answer.
Little nuclear staining was seen in Caco-2 cells, unlike the endothelial and mammary 
epithelial cell lines previously discussed. However, moderate levels of XOR were 
detected via electron microscopy (see Appendix) and low levels of nuclear XOR were 
detected by means of Western blot (data not shown). Statistical analysis of the gold
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labelling for XOR generated by electron microscopy showed significantly higher 
levels of nuclear labelling than that seen in other cell lines. However, the inability to 
support this with the localisation seen under the confocal microscope casts doubts 
upon the authenticity of these results. It would seem that levels of XOR within the 
nucleus of these cells are significantly lower than that seen in mammary epithelial and 
endothelial cells. This could reflect the level of maturity and specialisation of these 
cells compared to the other cell lines studied. Nuclear staining did seem to be largely 
dependent on the cell type and cell density in all the cell lines studied. Endothelial 
cells (see Chapter 5) showed intense nuclear staining for XOR in post-confluent cells, 
with much weaker nuclear staining in sub-confluent cells. Mammary epithelial cells 
(see Chapter 6) showed much more consistent nuclear localisation of XOR that 
seemed independent of cell density. This variation in itself suggests that XOR has a 
cell or tissue specific function as opposed to a general housekeeping function.
Whilst the localisation of XOR in endothelial and mammary epithelial cells was very 
similar (see Chapters 5 and 6) the nuclear staining and putative localisation to the cell 
junction in Caco-2 cells seemed to be unique to the cell type. These results are 
supportive of an alternate physiological function to that of purine catabolism.
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8 O v e r a l l  D is c u s s io n
Although several different cell lines were studied, a number of general points emerge. 
Prominent among these is the evidence of ‘vesicle-like’ association of XOR 
molecules within the cytoplasm
In the confocal microscope studies described in this thesis, the punctate nature of 
cytoplasmic staining, suggestive of vesicular packaging, was, in many cases, 
strikingly obvious. This was less apparent in the confocal images shown by Rouquette 
et al (1998); a fact that may reflect the earlier use of polyclonal antibodies as apposed 
to the present employment of high affinity monoclonals.
Rouquette and coworkers (1998) demonstrated localisation of XOR on the outer 
surface of endothelial cells, as did Vickers et al (1998), using monoclonal antibodies. 
In the present work, I was unable to explore extracellular localisation with confidence 
because the fixing processes, however mild, always led to antibody penetration of the 
plasma membrane. Nevertheless, I found that, in many cases, XOR was concentrated 
towards the outer periphery of the cytoplasm, particularly in those areas apposed by 
neighbouring cells (Figs. 5.11,5.21). These findings complement the similar 
localisation of extracellular enzyme shown by Rouquette et al (1998) and proposed by 
them to reflect an intercellular signalling role for XOR
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If, for the sake of discussion, the punctate cytoplasmic staining represents vesicular 
location of XOR, then the enzyme could be seen as being transported to the plasma 
membrane for eventual export to the outer cell surface, where it assumes a signalling 
or other function. Support for this paradigm is provided by electron microscopy. In 
these studies, two different resins were used for embedding, each with its peculiar 
strength and weakness. The requirements of sample preparation were such that one 
resin showed good definition of cell ultrastructure, but low density of antigen, while 
the other gave higher antigenic density with poorly preserved ultrastructure. 
Nevertheless, use of the two resins in parallel indicated strongly that XOR was often 
packaged within vesicle-like bodies (Figs. 5.4, 5.6, 5.7, 6.4-6.6, 7.3-7.6). Moreover, 
such vesicles were seen, in particular cases, to be either emerging from Golgi-like 
structures or approaching and merging with the plasma membrane (Figs. 5.5, 5.8, 6.8- 
6.10,1.1-1.9)
Apart from the histochemical evidence cited above, further support for the cellular 
export of XOR is provided by Partridge et al (1992), who reported that the enzyme is 
constitutively released from microvascular endothelial cells. The question arises as to 
what extent such export is compatible with established secretory mechanisms. XOR 
lacks an N-terminal signal sequence (Ichida et al, 1993) and so is not an obvious 
candidate for the classic biosynthetic and secretory pathway of proteins destined for 
export from the cell or incorporation into the plasma membrane (Stroud and Walter,
1999). This does not necessarily exclude XOR from targetting to the ER and 
incorporation into the above secretory pathway, as recent work has shown that signal 
sequences can occur at the C-terminus (Holscher et al, 2001) or even internally 
(Ouzzine et al, 1999) in proteins destined for the ER. There is also the possibility that
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XOR enters the ER by post-translational protein translocation. Very little is known 
about the targetting mechanism employed during this translocation mode and, 
whereas in mammalian cells only short polypeptides have been shown to enter the ER 
in this manner, S. cerevisiae are able to translocate large precursors (Kalies and 
Hartmann 1998). The fact that XOR contains disulphide bonds (Godber 1998), a post- 
translational modification that takes part in the ER (Frand et al, 2000), supports this 
possibility.
Regarding intracellular progress subsequent to incorportation into the ER, proposed 
routes of newly-synthesised proteins and glycoproteins through the various 
compartments of the Golgi and beyond, are constantly increasing and several 
possibilities exist. Many of the structures seen in the present work are too large 
(approx. 0.5-lpm) to be coated vesicles. However, recent opinion suggests that coated 
vesicles may represent a minority of the carriers that operate within the secretory 
pathway (Glick, 2000). It is possible that the enzyme is contained within large 
polymorphic structures known as secretory vesicles that emerge from the trans Golgi 
network to travel to the plasma membrane (Glick, 2000). Another alternative to COP 
1 coated vesicles are ‘megavesicles’, recently reported by Volchuk et al (2000), 
electron micrographs of which are strikingly similar to those seen containing XOR in 
this study.
Whatever the trafficking pathway, it is conceivable that XOR could associate, at an 
early stage, with glycosaminoglycans (GAGs) and/or syndecans, which occur on the 
cell surface and need to be transported there. XOR is known to have high affinity for 
GAGs (Radi et al, 1997) and may even make its way to the cell surface ‘piggy-back’
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on such structures, which are transported to the outer surface of the cell, where they 
remain anchored as part of the extracellular matrix. XOR is known to be associated 
with GAGs on the outer surface of vascular endothelial cells and evidence has been 
presented for internalization and reexport of the enzyme (Houston et al, 1999). 
Presumably, such processes involve localisation of XOR to endosomes and it may be 
that some of the larger ‘vesicular’ structures seen in confocal microscopy (eg. Figs. 
5.13, 5.14) correspond to this process.
From the data in this thesis and from those of Rouquette et al (1998), export of XOR 
to the outer surface of endothelial cells, seems to be established. The question then 
arises as to its physiological role in this location. Discussion is necessarily speculative 
and must acknowledge that it is based on experimental data in cultured, immortalised 
cells, with limited relevance to the in vivo situation. Nevertheless, some observations 
may be significant. As noted above, XOR tends in many cases to be concentrated in 
peripheral regions of the cell that were directly apposed to those of neighbouring 
cells. This suggests involvement of the enzyme in intercellular signalling, particularly 
in the latter stages of monolayer formation. Such signalling could involve superoxide, 
hydrogen peroxide or indeed NO, although we have no direct evidence for any of 
these. In this context, it is noteworthy that XOR activity in the cell cultures overall 
rises dramatically as the monolayer forms (Fig 5.1). A further, and particularly 
interesting potential example of intercellular signalling is seen in the mixed cell 
cultures, CPA, in which extensions of endothelial cells, apparently reaching toward 
neighbouring smooth muscle cells (see Fig 5.21), show high density of XOR. It is 
tempting to see this as a manifestation of NO-mediated endothelial signalling to 
smooth muscle; an established physiological process (Moncada et al, 1991).
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Similar evidence of export of XOR to the cell surface was obtained in epithelial cells. 
In the case of HB4a mammary cells, confocal microscopy again showed punctate 
staining (Figs 6.14, 6.15) and evidence of localisation of XOR to Golgi or ER was 
provided by electron microscopy (Figs 6.4, 6.5, 6.9, 6.10). Although HB4a cells do 
not actually generate milk fat globules, incoporation of XOR in the milk fat globule 
membrane requires the presence of the enzyme in the plasma membrane of the 
mammary cell and the present data can be seen as evidence that XOR is involved in a 
secretory pathway.
The distribution of XOR in Caco-2 cells is particularly interesting. Derived from 
intestinal epithelial cells, Caco-2 cells in culture grow first to a monolayer, parts of 
which subsequently develop domes. Domes are seen as an advanced stage of 
differentiation in these cells, representing the intestinal epithelial cell layer with its 
villi and tight junctions
In this context, the relationship between localisation of XOR and development of the 
cell culture is noteworthy. Prior to and at the monolayer stage, the enzyme is seen to 
be distributed throughout the cytoplasm. As in the other cell types studied here, both 
confocal and electron microscopic data are consistent with packaging of the enzyme 
in vesicles, at least some of which are presumably destined for export to the cell 
surface (Figs. 7.3 -  7.9, 7.14 -  7.15). At a later stage, single cell and multicellular 
domes develop and the distribution of XOR changes accordingly. In single ‘dome’ 
cells, XOR is uniformly distributed around the periphery forming a relatively dense 
layer. Finally, in the most highly differentiated multicellular domes, grown on cell 
culture inserts, the distribution of XOR changes again and most dramatically,
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apparently becoming concentrated in the tight junctions. Evidence for this latter 
localisation comes from the strikingly similar ‘hairnet’ confocal images of XOR and 
ZOl, a tight junction protein (Figs. 7.24, 7.25, 7.29) and, more convincingly, from 
co-localisation of XOR and catenin P, another junctional protein (Figs. 7.30 -  7.32).
In so far as the multicellular domes constitute a model of the mature intestinal 
epithelium, localisation of XOR to tight junctions is perfectly understandable in terms 
of the antibacterial barrier function assigned to the latter (Uzzau and Fasano, 2000). In 
fact, this pattern of XOR localisation was especially prominent in the cells that had 
been grown in co-culture (Section 7.4.2) designed to induce the development of high 
transcellular resistance, tight junctional complexes and restricted permeability 
(Garberg 1998). Tight junctions are dynamic structures that adapt readily to a variety 
of developmental, physiological and pathological circumstances (Uzzau and Fasano, 
2000). However, certain bacteria are able to exert an irreversible effect on the 
permeability and cytoskeletal structure of the tight junction via toxins, such as those 
produced by Clostridium difficile, Bacteroides fragilis and Vibrio cholerae, or via 
polymorphonuclear cells utilised by Salmonella and Shigella (Uzzau and Fasano,
2000). XOR can be seen as a defence against such processes.
The presence of XOR in tight junctions of intestinal epithelial cells clearly 
presupposes export of the enzyme from the cell and evidence of an antibacterial role 
for extracellular XOR in the gut has been provided by Van den Munckhof et al 
(1995), who have shown striking electron micrographic evidence of disintegrating 
bacteria surrounded by XOR.
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An antibacterial role for intestinal epithelial cell XOR, whether in tight junctions or 
excreted, can be seen as complementary to a similar role for XOR on the surface of 
the MFGM in the neonatal gut. In either location, XOR might be expected to actively 
seek out bacteria by virtue of its ability to bind to acidic glycosaminoglycans (Radi et 
al., 1997) commonly found on bacterial surfaces.
Van den Munckhof and coworkers (1995) assumed that the antibacterial activity of 
XOR depended on its ability to generate hydrogen peroxide and superoxide anion. It 
could also depend upon the generation of nitric oxide and, more especially, 
peroxynitrite, resulting from XOR-catalysed nitrite reduction (Godber et al, 2000ab). 
In support of this idea, fresh milk has recently been shown to inhibit the metabolic 
activity of a pathogenic bacterium in a nitrite-dependent process. Using E. coli 
transfected with the lux operon, Hancock et a l (2002) were able to use 
chemiluminescence to monitor metabolic activity, which was shown to be 
significantly impaired in the presence of fresh bovine or human milk. These 
bacteriostatic effects were dependent on the presence of nitrite and were abolished by 
heating the milk or in the presence of the specific XOR inhibitor, oxypurinol (Fig 
8.1). Moreover, the inhibition was only observed at low oxygen tensions, consistent 
with the known competition of nitrite and molecular oxygen for XOR-generated 
electrons (Godber et al, 2000b). Bacteriostatic activity of XOR in other contexts is 
illustrated by its demonstrated contribution to host defence against Burkholderia 







Fig 8.1: The effect o f bovine milk on the metabolism o f E. coli. E. coli isolate 16906, transformed with 
the luxCDABE operon, was resuspended in a luminometer cuvette with lOpM pterin and 20mM sodium 
nitrite at 0.63% oxygen tension. Light emissions were recorded before and after the addition o f milk 
(lml). No reduction in light emission was seen with milk treated with 25pM oxypurinol. Similar results 
were obtained with human milk (hot shown).
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The pattern of XOR activity seen in endothelial cells (Fig.5.1) may provide clues 
regarding enzyme function. The initial peak of activity, seen as the cells reach 
confluence, can be seen as reflecting involvement of XOR in intercellular signalling 
as the cells move towards confluence. A second peak is attained when the cells in the 
monolayer begin to die off and possible roles for XOR in the latter process should be 
considered. ROS and peroxynitrite are known to lead to profound biological 
consequences, including apoptosis and even mutation (Maeda and Akaike, 1998). In 
the present work, however, attempts to link apoptosis with XOR expression were 
inconclusive. Nevertheless, confluent and post-confluent endothelial cells showed 
marked staining of the nucleus. Enzyme was seen to be concentrated at the nuclear 
membrane and even at nuclear pores, suggesting involvement in transcriptional 
control. Unfortunately, such temporal association of subcellular distribution of XOR 
was not apparent in the other cell types studied. Mammary epithelial cells generally 
showed intense nuclear staining regardless of cell density, while intestinal epithelial 
cells showed very little staining at any stage of development. The latter observation is 
of interest in view of the apparent association of XOR with the proteins of tight 
junctions. ZO-2, which localises to tight junctions of confluent cells, is found in the 
nucleus of sub-confluent cells and migrates to the cell surface as confluence is 
attained (Islas et al, 2002).
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9  A p p e n d i x
Controls
Localisation by means of electron microscopy, secondary antibody only
EA-hy-926 cells exposed to the secondary antibody only, very little non-specific labelling is seen 
(magnification x40,000)
HB4a cells exposed to the secondary antibody only, very little non-specific labelling is seen 
(magnification x40,000)
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Caco-2 cells exposed to the secondary antibody only, very little non-specific labelling is seen
(magnification x60,000)
Localisation by means of electron microscopy, monoclonal anti-golgi antibody
EA-hy-926 and HB4a cells respectively subjected to the same staining protocol as other samples 
excepting that the primary mouse anti-human XOR monoclonal antibody was replaced with a 
mouse anti-human golgi apparatus monoclonal antibody (magnificationx50,000)
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Localisation by means of confocal microscopy, secondary antibody only
EA-hy-926 and ECV-304 cells respectivly, stained with secondary antibody FITC conjugate only. Some 
non-specific staining is seen but levels are low compared to samples where a primary antibody is also 
used
HB4a and Caco-2 (grown on coverslips)cells respectivly, stained with secondary antibody FITC 
conjugate only. Some non-specific staining is seen but levels are low compared to samples where a 
primary antibody is also used
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Caco-2 FITC and Caco-2 TRITC (grown on insets) cells respectivly, stained with secondary antibody 
only. Some non-specific staining is seen but levels are low compared to samples where a primary 
antibody is also used
Secondary only controls for both electron microscopy and confocal microscopy where 
performed for each batch of staining with whichever secondary atnibody conjugate 
that was used. The images shown here are an example of those routinly seen, as 
hundreds of control images were obtained. If background levels were above those 


























Statistical analysis o f gold labelling
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Level of gold labelling seen in various areas within the cells
■  Caco-2
■  EA-hy-926 
□  HB4a
Membrane associated Vesicles' Other organelles and Nucleus Film
cytosol
Statistical analysis showing significance o f labelling by the y 2 test
Observed Expected Observed Expected Observed Expected
Caco-2 EA-hy-926 HB4a
Abutting 87 42.75 29 29.75
Apical 13 42.75 55 29.75
Basal 23 42.75 3 29.75
Main body 48 42.75 32 29.75
Average 42.75 29.75
Chi Test
(P value significance level) 1.931E-16 6.66E-10
Plasm a membrane 2 17.66666667 2 10.6 2 10
Nuclear m em brane 2 17.66666667 8 10.6 2 10
Golgi apparatus 15 17.66666667 4 10.6 16 10
Large 'pockets' 17.66666667 11 10.6 4 10
Small 'pockets' 37 17.66666667 55 10.6 20 10
Mitochondria 17.66666667 4 10.6 10
Nucleus 47 17.66666667 8 10.6 24 10
Unidentified organelle 17.66666667 5 10.6 10
Cytosol 17.66666667 5 10.6 6 10
Film 3 17.66666667 4 10.6 6 10
Average 17.66667 10.6 10
Chi Test
(P value significance level) 1.32E-19 7.927E-41 3.19E-08
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Primary cells
There was some concern that the inability to obtain reproducible data for NO 
production was an artefact of using a permanent cell line. Discrepancies between the 
characteristics and behaviour of primary cells and their immortalised counterparts 
have been revealed in other reports (Claise, Edeas, Chaouchi et al, 1999). To rule this 
out primary white blood cells were obtained from fresh blood (as per Section 4.3) and 
subjected to NO analysis (as per Section 4.5). No activity could be detected in these 
cells, despite the fact that XOR has been localised and enzyme activity has been 
detected in leucocytes (Hellsten, Hansson, Johnson et al, 1996). This suggested that 
the failure to detect NO from some cells and the lack of reproducible data from others 
was a function of the assay, due to the complexity of working with a whole cell 
system or a reflection of the low levels of XOR activity seen in all human cells 
irrespective of whether the cells originated from a cell line or a primary cell source.
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